rfhg_127371.1

Basic information about the TSS

---

TSS ID: rfhg_127371.1 Species: human Chr: chr10		Start: 79243473 End: 79243483 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D2365809,EH38E1482569)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB033050:185 GeneID: 57178 HGNC/MGI_ID: HGNC:16493 UniProt_ID: Nearer transcript ids and distances:

Gene_name: PPIF Gene_symbol: ZMIZ1 Gene_synonyms: FLJ13541 KIAA1224 MIZ RP11-519K18.1 Zimp10 hZIMP10 Gene_source: HGNC:16493

TATA-Box annotation

---

Distance to TSS:	-103991
Nearest PromoterID:	NM_005729
Entrez ID:	10105
Nearest Unigene:	Hs.381072
Nearest Refseq:	NM_005729
Nearest Ensembl:	ENSG00000108179
Gene Name:	PPIF
Gene Alias:	CYP3|CyP-M|Cyp-D|CypD
Gene Type:	protein-coding
CpG%:	0.100000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZMIZ1 p2@ZMIZ1 p3@ZMIZ1 p4@ZMIZ1 p5@ZMIZ1 p6@ZMIZ1 p7@ZMIZ1 p8@ZMIZ1 p9@ZMIZ1
Sample		p1@ZMIZ1	p2@ZMIZ1	p3@ZMIZ1	p4@ZMIZ1	p5@ZMIZ1	p6@ZMIZ1	p7@ZMIZ1	p8@ZMIZ1	p9@ZMIZ1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.74	1.75	2.14	0.00	0.19	0.19	0.00	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.70	1.62	1.82	0.20	0.00	0.20	0.40	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.65	2.12	2.31	0.00	0.19	0.00	0.00	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.90	1.04	1.87	0.00	0.21	0.00	0.42	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.22	1.57	2.02	0.00	0.22	0.22	0.00	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.27	1.16	2.71	0.00	0.39	0.39	0.58	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.97	0.87	2.61	0.22	0.22	0.00	0.22	0.22	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.96	0.73	2.91	0.00	0.24	0.24	0.48	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.98	1.71	4.06	0.00	1.07	0.21	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	1.74	4.06	0.00	0.58	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.66	1.62	1.21	0.00	0.00	0.00	0.00	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	4.07	0.81	2.44	0.00	0.41	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.22	8.87	0.00	0.48	0.00	3.55	1.13	2.10	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	59.54	6.77	0.00	0.15	0.00	2.71	1.95	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	52.91	8.56	0.00	0.00	0.00	1.76	1.32	1.76	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	57.09	4.78	0.00	0.25	0.00	1.51	2.26	1.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	57.66	6.99	0.00	0.66	0.00	0.87	1.53	1.09	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	61.16	7.17	0.00	1.69	0.00	0.42	1.27	3.37	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	75.71	5.86	0.00	0.00	0.00	2.67	2.13	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	49.65	8.27	0.00	0.75	0.00	2.86	1.20	2.26	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	59.07	6.95	0.00	0.13	0.00	2.00	0.94	0.94	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	66.98	8.29	0.00	0.35	0.00	1.90	1.90	1.38	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.98	6.59	0.00	0.26	0.00	2.07	1.29	2.20	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	72.31	6.55	0.00	0.00	0.00	2.18	0.97	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	97.26	16.00	0.00	0.26	0.00	1.81	1.03	1.55	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	108.25	21.21	0.00	0.00	0.00	1.90	0.63	1.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	110.44	14.29	0.00	0.55	0.00	1.65	3.30	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	119.76	22.16	0.00	0.94	0.00	4.72	1.41	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	85.28	16.96	0.00	0.32	0.00	3.39	0.65	0.97	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	89.76	15.02	0.00	0.00	0.00	3.62	0.90	1.45	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	74.95	9.63	0.00	1.05	0.00	3.14	1.47	2.51	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	93.98	13.09	0.00	0.39	0.00	2.34	0.59	1.76	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	91.80	12.87	0.00	1.27	0.00	2.32	1.48	4.01	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	81.65	14.18	0.00	0.82	0.00	1.32	2.31	3.30	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	70.50	13.28	0.00	0.19	0.19	2.43	2.43	1.68	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	81.63	14.95	0.00	1.15	0.00	2.87	0.96	2.11	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	76.03	12.67	0.00	1.23	0.00	2.45	2.45	3.07	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	83.01	15.51	0.00	0.60	0.00	1.01	2.22	4.43	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	91.83	14.05	0.00	1.08	0.00	3.24	4.05	6.48	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	77.06	9.60	0.00	1.20	0.00	2.88	2.40	2.40	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	74.34	13.41	0.00	1.88	0.00	3.06	1.88	3.06	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	75.98	13.32	0.00	1.61	0.00	2.49	3.22	4.10	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	70.65	15.18	0.00	1.27	0.00	2.74	3.59	4.64	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	73.60	13.46	0.00	0.87	0.00	2.62	1.92	3.32	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	73.28	11.24	0.00	0.80	0.00	3.21	1.41	3.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	57.00	5.82	0.00	0.93	0.00	2.79	2.33	1.86	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	59.26	11.76	0.00	0.96	0.00	2.88	1.44	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	52.46	8.05	0.00	0.30	0.00	1.79	0.30	1.79	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	61.28	7.18	0.00	0.00	0.00	2.87	0.00	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	48.93	6.87	0.00	0.20	0.00	1.82	1.01	0.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	68.25	6.15	0.00	0.61	0.00	1.43	1.43	1.84	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	81.61	7.56	0.00	1.56	0.00	1.56	0.89	2.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	53.58	7.10	0.00	0.71	0.00	1.06	0.71	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	61.31	6.96	0.00	0.66	0.00	1.99	3.31	3.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	47.82	6.71	0.00	0.84	0.00	0.84	4.19	2.52	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	47.76	5.51	0.00	0.92	0.00	2.30	1.38	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	63.20	3.24	0.00	0.00	0.00	1.30	1.30	3.24	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	53.31	4.50	0.00	0.64	0.00	2.25	1.28	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	55.32	4.09	0.00	0.94	0.00	0.31	2.20	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	44.42	3.53	0.00	0.71	0.00	1.41	2.82	4.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.65	2.80	0.00	0.56	0.00	0.56	0.56	2.80	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	40.60	4.78	0.00	0.00	0.00	0.80	0.80	3.18	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	43.49	3.74	0.00	0.68	0.00	1.02	2.04	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	54.91	5.20	0.00	0.00	0.00	0.97	1.62	1.95	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.30	2.48	0.00	0.00	0.00	1.06	1.42	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	2.44	0.00	0.00	0.00	0.00	1.46	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.34	1.49	0.00	0.00	0.00	0.00	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	20.17	0.47	0.00	0.00	0.00	0.00	0.00	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.88	1.32	0.00	0.66	0.00	0.00	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	1.55	0.00	0.31	0.00	0.31	0.93	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.20	3.97	0.00	0.00	0.00	0.92	0.61	0.92	0.92
Adipocyte - breast, donor1	11376-118A8	49.89	5.07	0.16	0.48	0.00	0.63	0.79	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	47.17	3.85	0.00	0.96	0.00	0.16	2.41	4.01	0.96
Adipocyte - omental, donor1	11473-119C6	62.72	5.98	0.00	0.38	0.00	0.76	0.76	0.76	0.51
Adipocyte - omental, donor2	11474-119C7	29.90	1.49	0.00	0.75	0.00	0.00	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	42.87	5.02	0.00	0.00	0.00	1.00	0.67	2.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	29.35	2.55	0.00	0.00	0.00	0.00	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	20.77	0.90	0.00	0.00	0.00	1.35	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	60.13	6.78	0.17	0.00	0.00	1.39	1.22	0.70	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	82.34	10.17	0.59	0.00	0.59	1.96	0.20	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	75.41	6.95	0.00	1.03	0.26	1.03	0.51	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	66.07	5.85	0.00	0.56	0.00	1.12	0.84	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	112.86	7.64	0.59	0.59	0.00	1.76	1.18	2.94	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	69.41	8.53	0.08	0.08	0.00	1.61	0.72	0.72	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	87.14	10.01	0.00	0.97	0.00	1.94	0.32	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	79.98	7.46	0.00	0.53	0.53	2.13	1.07	3.73	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	73.45	6.68	0.00	0.00	0.00	1.11	0.00	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	28.28	5.41	0.00	0.00	0.42	0.00	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	52.24	6.28	0.75	0.00	0.75	1.00	0.50	1.26	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	50.07	5.89	0.00	0.00	0.00	0.33	0.33	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	35.32	2.74	0.00	0.30	0.00	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	22.10	1.10	0.22	0.22	0.22	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	12.91	0.72	1.79	0.36	0.00	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	1.20	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.66	0.18	1.26	0.18	0.18	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.27	1.03	0.21	0.00	0.00	0.21	0.62	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.73	3.20	0.46	0.00	0.34	1.49	0.57	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	30.37	2.69	0.98	0.24	0.73	0.98	1.71	0.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.02	1.35	0.00	0.00	0.00	0.45	0.45	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.40	1.74	0.00	0.00	0.00	0.00	0.43	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.22	1.49	0.00	0.00	0.30	0.00	0.60	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	2.53	0.00	1.26	0.00	1.26	0.00	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	0.00	0.00	0.00	0.66	0.00	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.02	0.00	0.00	0.00	0.00	0.32	0.00	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	1.46	0.00	0.00	0.00	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	18.41	1.19	0.00	0.00	0.00	0.59	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.84	1.13	0.00	0.00	0.00	0.75	1.13	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	0.73	0.00	0.00	0.00	0.00	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.64	1.32	0.00	0.00	0.00	0.66	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.89	1.36	0.00	0.00	0.00	0.15	0.15	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	25.72	3.75	0.00	0.00	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.00	1.32	0.00	0.00	0.00	0.38	0.19	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.51	1.07	0.00	0.53	0.00	0.00	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	1.95	0.00	0.00	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.42	1.33	0.17	0.00	0.00	0.17	0.33	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.78	1.37	0.17	0.17	0.00	0.34	0.86	1.20	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.27	2.43	0.49	0.00	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.21	1.52	0.38	0.00	0.00	0.76	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	0.00	0.00	0.00	0.00	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.67	2.28	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.89	1.71	0.21	0.21	0.00	0.86	0.21	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.26	0.77	0.00	0.00	0.00	0.52	0.77	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.77	0.47	0.00	0.00	0.00	0.47	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	1.29	0.00	0.32	0.00	0.64	0.00	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.75	0.90	0.00	0.00	0.00	0.60	0.60	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	1.19	0.00	0.00	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	19.83	1.53	0.00	0.51	0.00	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.75	1.53	0.00	0.00	0.00	0.51	0.51	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	2.54	0.00	0.00	0.00	0.00	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.81	0.43	0.00	0.00	0.00	1.29	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.53	0.85	0.00	0.00	0.00	0.42	0.21	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.02	0.58	0.29	0.00	0.00	0.29	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.95	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	0.85	0.00	0.00	0.00	0.51	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	2.32	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	2.11	0.00	0.00	0.00	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.01	1.07	0.00	0.00	0.00	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.85	0.73	0.00	0.00	0.00	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.55	0.69	0.00	0.23	0.00	1.15	0.23	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	2.55	0.00	0.00	0.00	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.93	1.53	0.00	0.00	0.00	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.99	0.83	0.00	0.00	0.00	0.21	0.41	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.58	0.61	0.00	0.00	0.00	0.92	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	0.48	0.00	0.00	0.00	0.48	0.48	1.43	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.08	1.55	0.00	0.00	0.00	0.44	0.22	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.83	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.21	1.85	0.00	0.00	0.00	1.06	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.54	0.36	0.00	0.00	0.00	0.36	0.36	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	98.13	10.32	1.23	0.49	2.09	1.60	0.74	0.86	0.25
Astrocyte - cerebellum, donor2	11580-120F5	68.46	7.87	0.86	0.17	1.54	3.25	0.86	2.57	0.51
Astrocyte - cerebellum, donor3	11661-122F5	59.15	9.44	1.05	0.00	0.63	1.05	0.21	1.26	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	50.54	5.23	3.14	0.00	0.35	1.74	0.00	1.74	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	76.20	5.82	4.85	0.49	1.29	2.10	2.59	1.29	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	47.73	3.58	5.37	0.00	1.19	1.79	1.04	0.60	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.28	3.33	8.37	0.11	13.19	0.00	1.83	0.11	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.38	1.88	10.40	0.25	14.66	0.00	1.38	0.25	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.84	2.28	9.90	0.11	14.34	0.11	1.93	0.00	1.14
Basophils, donor1	12241-129G9	72.44	14.91	8.89	0.00	2.62	0.78	0.26	0.00	0.26
Basophils, donor2	12242-129H1	70.36	20.93	6.86	0.36	3.61	0.00	0.00	0.36	0.36
Basophils, donor3	12243-129H2	77.91	20.14	16.46	0.00	10.00	1.47	0.44	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	15.09	3.67	0.43	0.22	0.43	0.22	0.43	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	20.57	0.91	0.00	0.00	0.00	0.00	1.37	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.67	0.00	0.00	0.00	0.00	0.63	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.02	1.25	0.00	0.00	0.00	0.00	0.21	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	11.05	1.84	0.00	0.23	0.00	0.23	0.46	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	17.45	1.80	0.00	0.18	0.00	1.08	0.36	0.72	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.64	2.27	2.99	0.00	1.75	0.00	0.00	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	1.63	0.93	12.11	0.00	8.15	0.00	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	103.61	29.42	0.00	0.00	0.00	0.96	0.00	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	103.13	22.54	19.16	0.00	6.76	2.25	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	133.63	31.55	18.00	1.67	9.09	2.23	3.16	1.86	1.30
CD14+ Monocytes, donor3	11381-118B4	99.23	27.22	14.71	0.44	6.81	1.10	0.44	0.66	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	110.10	35.66	0.00	0.00	0.00	0.28	1.70	0.57	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	94.39	28.05	1.14	0.00	0.76	1.90	1.52	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	111.11	32.22	0.00	0.66	0.00	1.31	1.31	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	141.66	22.55	26.16	1.73	15.03	0.87	16.33	4.19	7.08
CD14+ monocytes - mock treated, donor2	11873-125C1	95.05	23.23	19.61	2.72	25.35	2.11	17.50	2.11	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	140.00	25.35	23.93	2.61	25.35	1.42	13.98	1.90	5.21
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	93.58	12.55	17.07	2.68	9.54	0.50	8.87	1.84	2.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	80.32	16.56	24.57	1.38	20.98	0.55	9.94	1.10	6.07
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	88.51	18.59	21.07	1.49	17.85	0.99	5.21	0.50	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	59.92	10.38	14.69	1.17	6.66	0.39	7.64	1.17	2.55
CD14+ monocytes - treated with BCG, donor2	11870-125B7	63.56	13.89	20.12	1.60	14.07	0.53	6.41	0.89	2.85
CD14+ monocytes - treated with BCG, donor3	11880-125C8	56.37	11.75	11.75	0.87	8.49	0.00	4.13	0.65	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	69.54	10.77	6.32	0.47	2.58	1.40	1.17	0.70	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	80.79	17.95	15.31	0.00	10.03	1.06	2.64	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	90.97	17.75	17.75	2.22	9.98	0.00	3.33	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	108.44	22.31	21.57	3.42	13.24	0.89	13.98	1.78	4.76
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	90.00	15.37	23.35	3.59	25.34	1.20	12.77	0.00	4.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	66.42	13.12	10.20	1.46	13.53	0.21	8.95	0.83	2.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	96.78	16.93	14.18	2.06	7.09	1.37	6.41	1.60	3.66
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	82.56	16.06	16.29	1.13	12.89	0.45	6.56	0.23	3.17
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	86.86	16.59	20.08	0.44	11.78	0.44	6.98	2.62	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	85.54	12.91	17.75	2.96	10.49	0.00	11.84	1.08	3.77
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	92.64	16.57	16.57	2.79	15.53	0.52	15.18	1.40	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	104.78	20.20	26.93	2.95	19.36	0.84	8.42	2.95	4.21
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	71.10	10.47	9.74	1.65	3.12	1.10	3.67	1.10	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	72.92	15.85	14.80	1.76	11.27	0.70	3.17	0.70	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	82.92	14.92	9.65	1.32	7.46	0.88	1.75	0.44	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	68.53	11.68	13.43	2.44	6.63	0.87	6.97	1.05	2.62
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	84.74	19.70	20.44	1.49	13.75	1.49	5.20	1.49	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	63.80	15.09	11.42	0.65	9.70	1.29	3.45	0.22	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	65.52	9.42	7.37	2.46	2.05	0.00	2.05	1.23	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	68.38	15.99	10.20	0.70	5.10	0.23	2.55	0.70	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	58.00	10.67	6.73	0.23	4.18	0.46	0.93	0.46	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	67.57	10.90	1.31	0.00	1.74	0.87	0.22	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	88.24	10.63	3.00	0.46	1.85	0.46	1.62	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	63.69	9.96	2.17	0.22	1.95	0.43	0.22	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	83.62	13.08	3.74	0.31	1.71	0.47	1.09	0.62	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	65.14	12.92	2.27	0.17	1.75	0.35	1.22	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	91.86	23.86	3.12	0.45	2.68	0.45	1.11	0.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	111.51	9.95	2.30	0.00	0.26	0.51	0.51	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	86.51	7.25	1.32	0.00	0.66	0.44	1.10	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	70.74	10.95	0.84	0.00	0.84	0.00	0.63	1.26	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	0.00	0.00	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.03	0.68	1.36	0.00	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	0.00	2.07	0.00	4.14	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.00	1.60	1.60	0.00	2.13	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.61	1.61	0.54	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.11	2.81	0.70	0.00	2.11	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	2.35	2.35	0.78	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	4.11	3.29	2.47	0.00	4.93	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	2.90	6.53	0.00	5.80	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	8.08	2.52	2.52	0.00	3.03	0.00	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	47.27	16.57	0.00	0.00	0.40	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	42.35	19.18	0.00	0.00	0.00	0.00	0.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	143.58	40.16	2.01	0.00	2.01	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	82.02	33.71	2.81	0.00	3.93	1.69	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.24	20.29	0.00	0.00	0.00	0.38	0.75	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	78.02	24.58	0.23	0.23	0.68	0.23	0.45	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	27.49	14.64	0.71	0.00	0.00	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	42.25	16.53	0.61	0.00	0.00	0.00	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	32.02	15.55	0.30	0.00	0.00	0.00	0.30	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.76	8.93	0.77	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	11.90	12.35	0.22	0.00	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	11.79	0.29	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.70	8.06	0.00	0.00	0.00	0.00	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	26.69	21.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.71	8.24	1.73	0.43	0.58	0.00	0.29	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.08	3.73	1.86	0.17	0.34	0.00	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	6.93	5.64	0.64	0.00	0.64	0.00	0.16	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.00	9.41	0.90	0.00	0.90	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.96	9.43	0.00	0.35	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	19.36	12.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	9.70	15.60	1.26	0.00	2.95	0.00	1.26	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.74	14.34	3.12	0.00	2.08	0.00	0.83	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.03	12.36	1.34	0.00	1.67	0.00	0.33	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.79	8.43	0.54	0.00	0.00	0.00	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.05	20.90	0.00	0.00	2.14	0.00	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	19.73	0.00	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	21.32	14.46	1.67	0.37	1.30	0.00	0.19	0.56	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.86	11.70	1.95	0.22	1.08	0.00	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	16.39	13.87	1.47	3.15	0.63	0.00	0.42	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	14.16	10.62	0.00	0.00	0.00	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	18.63	13.43	0.43	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	26.58	13.07	0.00	0.00	0.44	0.00	0.87	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.33	10.39	0.49	0.00	0.00	0.00	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	8.31	0.92	0.00	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	11.17	5.58	1.40	0.00	0.00	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	22.15	18.83	0.55	1.94	0.28	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.99	15.21	0.49	3.19	1.23	0.00	0.25	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	12.32	1.54	0.00	1.54	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.13	12.18	0.72	0.00	1.07	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	16.62	9.69	0.00	0.00	0.00	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	16.70	13.10	1.96	0.33	1.64	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	18.02	6.76	1.50	1.13	0.00	0.00	0.38	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	18.43	11.36	2.52	2.78	0.00	0.00	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.16	2.06	2.98	0.00	6.19	0.46	1.61	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.50	3.12	4.07	0.00	10.78	0.00	0.72	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.41	3.56	4.10	0.27	6.84	0.27	0.82	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.01	2.70	0.90	0.00	7.21	0.30	0.60	1.50	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	5.28	3.12	0.00	10.56	0.48	1.92	0.96	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.73	4.78	3.64	0.00	6.82	0.00	0.68	1.36	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.56	5.43	3.69	0.22	5.00	0.22	0.87	1.09	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	4.47	1.58	0.00	6.58	0.00	0.26	1.05	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.06	4.22	4.46	0.23	8.44	0.23	0.94	0.94	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.19	3.02	3.32	0.60	6.04	0.30	0.91	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	23.53	3.78	4.94	0.00	8.13	0.00	0.87	0.87	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.19	5.06	5.06	0.27	6.13	0.00	0.53	0.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.14	5.25	5.69	0.00	7.88	0.44	0.44	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.79	3.64	6.83	0.46	7.74	1.82	3.64	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	5.97	3.73	0.00	6.71	0.75	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.57	5.40	4.68	0.00	10.08	0.00	0.72	0.36	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.13	4.32	2.59	0.00	9.78	0.58	0.58	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	3.77	3.54	0.24	8.01	0.24	0.47	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.87	5.39	0.95	0.00	9.19	0.32	0.63	0.95	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.22	4.00	1.54	0.62	9.23	0.00	0.92	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	19.24	5.45	4.17	0.00	5.45	0.00	0.64	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	3.44	3.82	0.38	6.50	0.00	1.15	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.55	2.36	4.34	0.00	4.73	0.00	0.79	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	6.05	2.27	0.00	8.32	0.76	1.51	2.27	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	12.04	5.62	0.00	11.24	0.00	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	9.79	4.90	0.00	7.69	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	31.05	14.02	3.01	0.00	9.02	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	65.80	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	2.96	0.49	0.00	0.00	0.49	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	13.15	2.21	0.00	0.42	0.11	0.21	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	44.03	4.51	0.35	11.44	0.35	2.77	0.69	1.39	0.35
Chondrocyte - de diff, donor2	11338-117F6	56.86	9.95	0.00	7.46	0.00	2.49	1.07	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	49.61	5.35	0.11	9.33	0.23	2.39	1.37	1.25	0.46
Chondrocyte - re diff, donor2	11339-117F7	64.46	9.85	0.90	13.43	0.90	1.79	0.00	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	71.98	9.71	0.00	27.50	0.00	4.04	1.21	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	71.49	7.69	0.23	0.34	0.23	1.72	0.23	0.57	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	64.13	7.91	0.43	0.21	0.21	1.50	1.28	1.92	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	53.01	5.04	0.00	0.18	0.35	1.59	0.44	0.71	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	78.77	16.60	2.93	12.29	2.75	1.28	0.83	0.64	0.37
Corneal Epithelial Cells, donor1	11526-119I5	15.59	0.88	0.22	27.23	0.00	0.22	0.00	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	1.14	0.00	17.06	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.04	1.53	0.00	20.45	0.51	0.00	0.00	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.89	6.44	1.98	0.00	0.99	0.17	0.17	0.17	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.34	6.62	1.89	0.00	1.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	6.90	0.00	0.00	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.92	5.08	0.43	0.32	2.70	0.32	0.43	0.86	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	48.51	38.26	1.71	0.34	1.02	0.34	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	35.25	20.24	1.96	0.00	0.65	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.49	35.33	0.00	0.00	0.97	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	23.85	3.34	0.00	0.00	0.33	0.33	0.17	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	17.02	4.69	0.59	0.00	0.00	1.17	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	28.56	1.41	0.00	0.00	0.28	1.13	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	17.69	1.97	0.00	0.00	0.39	1.18	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	16.58	2.33	0.00	0.00	0.29	1.75	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	17.88	1.88	1.41	0.24	0.00	1.18	0.00	0.94	0.94
Endothelial Cells - Artery, donor3	11413-118E9	17.53	1.75	0.53	0.18	0.35	0.70	0.18	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.39	3.77	0.00	0.22	0.66	0.66	0.44	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.69	4.56	0.91	0.00	0.61	0.91	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.19	4.23	0.00	0.00	0.00	0.00	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	11.29	2.67	0.30	0.00	0.30	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.58	2.08	0.00	0.00	0.52	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	17.16	3.26	0.00	0.00	0.43	0.71	0.43	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	12.40	2.00	0.40	0.00	0.00	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	1.05	0.00	0.00	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.18	3.73	1.37	0.37	0.62	0.50	0.75	0.37	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.46	3.26	1.30	0.22	0.43	1.52	0.43	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.30	4.15	1.83	0.24	0.49	0.73	0.24	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	13.65	3.41	2.28	0.00	1.14	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	1.40	0.70	0.00	1.40	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	18.21	2.67	2.20	0.00	0.79	1.10	0.31	0.79	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	128.72	54.46	37.96	0.00	54.46	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	82.04	71.34	14.27	0.00	17.83	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	15.88	1.22	0.24	0.00	0.00	0.49	0.24	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	8.32	0.00	0.00	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.93	1.64	0.41	1.23	0.00	1.23	0.41	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.04	0.44	0.00	0.11	0.00	0.33	0.66	0.55	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.94	1.41	0.00	0.54	0.00	0.43	0.76	1.19	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.53	1.33	0.00	0.36	0.00	0.49	0.36	0.61	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	29.34	1.91	0.00	0.00	0.00	1.64	0.14	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.84	2.32	0.00	0.11	0.00	1.05	0.63	0.95	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	72.46	7.11	0.00	0.26	0.26	2.63	1.58	1.32	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	46.84	5.32	0.33	0.33	0.00	1.66	1.33	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	37.65	2.72	0.00	0.00	0.00	2.72	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	27.29	1.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	32.02	1.89	0.00	0.32	0.16	1.89	0.63	1.89	0.00
Fibroblast - Cardiac, donor4	11452-119A3	38.19	4.85	0.00	0.00	0.00	0.30	0.30	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	20.43	1.78	0.13	0.00	0.00	0.89	0.38	1.27	0.13
Fibroblast - Cardiac, donor6	11460-119B2	19.10	1.36	0.30	0.00	0.15	0.91	0.30	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	41.54	4.15	0.94	0.00	2.41	1.21	0.27	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	78.52	6.47	0.86	0.00	0.86	1.73	0.00	2.16	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	2.93	1.46	0.00	1.46	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.53	2.77	0.00	0.46	0.46	0.23	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	23.74	2.54	0.17	0.51	0.17	0.34	0.17	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	10.33	0.94	0.00	0.00	0.00	1.41	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	15.09	1.89	0.00	0.00	0.94	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	13.42	1.21	0.00	0.00	0.24	1.45	0.36	0.24	0.36
Fibroblast - Dermal, donor4	11450-119A1	11.08	0.79	0.79	0.11	0.11	0.79	0.23	0.34	0.11
Fibroblast - Dermal, donor5	11454-119A5	15.88	1.40	0.70	0.17	0.70	0.70	0.17	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	14.62	0.81	1.79	0.16	0.65	0.16	0.65	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	26.86	1.87	0.00	0.42	0.00	1.04	0.21	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	53.45	4.45	0.00	0.79	0.26	1.31	0.79	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	29.52	2.50	0.53	0.40	0.13	1.58	0.40	0.79	0.40
Fibroblast - Gingival, donor3	11394-118C8	50.86	7.06	0.00	0.00	0.00	2.13	0.77	0.77	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	4.16	0.00	0.00	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	41.06	3.00	0.18	0.18	0.18	1.06	0.70	0.88	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	46.77	2.81	0.16	0.00	0.16	1.40	0.16	0.16	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	34.21	3.11	0.00	0.27	0.00	0.41	0.68	0.68	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	53.64	6.70	1.41	0.00	0.35	1.06	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.88	5.12	0.00	0.00	0.15	0.44	0.44	0.88	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.45	3.95	0.00	0.14	0.14	0.27	0.95	0.68	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.13	3.51	0.55	0.00	0.00	1.54	0.55	0.33	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	66.03	5.87	0.29	0.00	0.00	0.88	0.73	1.17	0.44
Fibroblast - Lung, donor1	11270-116H1	31.27	2.72	0.00	0.00	0.00	4.08	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	1.49	0.00	0.00	0.00	1.49	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	30.60	2.53	0.21	0.00	0.21	1.48	0.63	0.84	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	38.32	5.00	0.00	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	1.40	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.51	1.12	0.00	0.00	0.00	0.56	0.84	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	44.66	2.44	0.41	0.41	0.41	1.62	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	3.99	0.00	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.10	2.13	0.58	0.19	0.19	0.39	0.00	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.09	3.49	0.76	0.76	0.15	0.76	0.91	1.67	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	17.44	1.53	0.00	4.59	0.00	0.92	0.00	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	39.31	4.20	0.00	0.38	0.00	2.29	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.41	2.43	0.54	0.00	0.27	0.81	0.54	1.62	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	43.95	4.75	0.46	0.12	0.35	1.28	1.04	0.93	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.07	0.99	0.00	0.00	0.11	0.11	0.00	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	76.40	7.52	0.61	1.02	0.41	1.63	0.20	0.81	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.72	1.34	0.00	0.67	1.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.09	1.58	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	91.48	11.71	0.60	0.40	0.20	2.18	0.79	0.99	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.08	2.31	0.00	1.07	0.00	1.42	0.00	1.42	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	37.84	2.76	0.20	0.20	0.20	0.59	0.00	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	85.74	12.64	0.00	0.30	0.00	3.01	0.90	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.33	4.21	0.11	0.76	0.32	1.84	0.43	0.76	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	85.54	6.33	0.00	0.25	0.00	3.54	0.00	1.52	0.25
Fibroblast - skin normal, donor1	11553-120C5	39.87	3.28	0.16	0.66	0.00	0.49	0.33	0.33	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	93.24	8.22	1.00	0.20	0.00	7.82	0.80	0.80	0.80
Fibroblast - skin normal, donor2	11561-120D4	41.99	3.72	0.20	0.60	0.20	1.21	0.40	1.00	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	116.36	15.72	0.60	1.21	0.30	5.74	0.60	2.42	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.88	3.23	0.00	0.50	0.08	0.58	0.58	0.25	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.87	4.27	0.00	0.17	0.17	1.03	0.17	1.20	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	92.62	7.55	0.00	0.00	0.33	1.64	1.31	2.63	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.96	4.79	0.11	0.11	0.11	1.81	0.32	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	34.24	1.52	0.34	1.01	0.51	1.18	0.17	0.84	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.47	1.25	0.00	0.16	0.00	0.00	0.94	1.10	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	75.82	6.97	0.87	1.74	0.00	0.87	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.27	0.52	0.87	1.04	0.00	0.00	0.52	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.67	0.52	0.78	0.00	0.00	0.78	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	0.51	1.53	4.09	0.26	0.51	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	49.00	5.36	0.77	0.77	0.77	0.00	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.03	1.91	0.00	0.00	0.00	0.00	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	23.68	2.57	0.57	0.00	0.29	0.29	0.57	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.81	11.58	4.41	0.28	0.55	1.93	1.93	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	143.62	22.83	2.51	0.68	0.91	1.60	2.05	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	35.07	7.13	2.38	0.00	0.40	0.40	0.00	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	57.63	11.37	4.49	0.00	0.79	1.32	0.26	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	76.32	10.44	6.52	0.33	2.94	3.91	1.63	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	4.42	0.88	0.00	0.44	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.00	5.65	1.55	0.14	0.57	1.84	0.71	0.71	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.05	5.17	1.97	0.37	0.99	1.48	0.86	1.11	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	43.52	5.37	1.07	0.27	1.07	1.07	1.07	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.19	3.22	1.61	0.74	1.24	2.11	1.24	0.87	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	38.34	2.63	1.25	0.55	1.25	2.35	0.55	1.94	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.75	2.64	0.20	0.20	1.22	0.61	1.63	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.62	2.51	0.68	0.00	1.37	0.91	0.46	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.50	2.74	1.87	0.12	2.24	1.99	0.87	0.75	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	44.37	4.59	0.22	0.22	1.09	4.37	0.87	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	40.19	2.66	0.30	0.00	1.48	1.48	0.89	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.40	4.29	1.91	0.32	0.95	2.07	1.43	1.59	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.65	3.80	1.12	0.22	0.67	0.67	0.00	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.55	4.84	0.60	0.20	1.41	0.81	0.81	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.51	4.75	1.19	0.00	0.51	1.70	1.02	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	45.75	4.52	1.68	0.09	2.31	0.80	0.62	0.35	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.57	7.08	1.98	0.42	2.81	1.56	1.46	0.52	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.04	8.88	1.88	0.68	1.88	0.68	0.51	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	47.25	5.53	2.32	0.66	1.22	2.21	0.66	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.68	3.83	1.00	0.17	1.16	0.83	0.33	0.33	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.82	4.29	0.61	0.00	0.82	1.02	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	45.39	5.78	0.62	0.41	0.83	2.06	1.03	1.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.81	6.46	1.27	0.35	1.15	1.61	0.58	0.81	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	47.36	4.50	1.00	0.17	0.67	0.83	0.67	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.05	3.31	1.10	0.00	1.54	0.66	1.32	1.10	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.54	5.78	1.11	0.00	0.86	2.09	0.74	0.86	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	65.00	5.84	2.11	0.81	1.95	2.43	0.49	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.33	6.41	1.92	0.00	0.32	1.28	2.89	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.83	6.06	1.90	0.19	0.95	2.27	1.42	0.76	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.66	3.64	0.63	0.16	2.06	2.21	0.32	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	63.55	4.26	0.91	0.00	1.22	1.52	1.82	1.52	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.06	5.23	2.09	0.21	1.78	1.67	0.84	0.63	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	42.37	6.15	1.10	0.22	0.88	1.54	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	60.60	5.33	1.96	0.00	1.12	1.68	0.56	2.81	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	49.53	4.91	1.20	0.19	1.20	1.76	1.11	0.65	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.32	4.28	1.07	0.00	2.14	0.80	0.00	0.53	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	50.34	5.20	3.37	0.00	1.84	1.22	0.92	0.61	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	34.97	2.59	1.68	0.00	0.65	1.04	0.91	0.91	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	38.76	3.80	1.63	0.00	0.81	1.08	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.07	4.98	0.55	0.18	0.37	1.84	0.37	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	74.13	5.70	0.44	0.44	0.00	1.54	1.54	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	111.08	8.93	0.99	1.98	2.98	5.95	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.13	3.69	0.26	0.13	0.26	0.79	1.19	0.79	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.18	4.24	0.40	0.00	0.00	1.21	1.41	1.41	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	178.93	21.86	1.02	2.03	1.27	5.08	2.29	0.00	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	37.03	4.58	1.79	0.00	0.00	1.00	0.40	0.40	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	41.75	4.16	1.23	0.46	0.62	1.08	0.46	0.62	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.51	5.32	0.41	0.00	1.64	0.20	0.20	1.02	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	25.66	1.88	0.94	0.31	1.25	0.63	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.21	2.26	0.57	0.00	0.28	0.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	33.67	3.69	0.46	0.00	0.46	0.92	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	4.95	2.47	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	41.78	1.93	0.77	0.00	0.39	0.00	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	0.00	1.60	0.00	3.21	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	1.74	0.00	0.00	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.34	2.93	1.95	0.00	0.33	0.33	1.63	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	46.53	3.71	0.41	0.00	0.41	0.00	1.24	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	73.31	10.00	0.00	0.00	0.00	0.00	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	52.85	4.19	1.12	0.00	1.40	0.84	1.40	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	38.57	2.61	0.65	0.65	0.98	0.33	0.00	1.31	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	83.04	3.36	2.52	0.84	2.52	3.36	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	72.52	5.73	0.95	0.00	0.64	1.91	0.64	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.55	1.36	0.00	0.00	1.02	0.34	0.34	2.04	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	8.35	0.00	0.00	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	58.42	8.59	0.57	0.57	0.00	0.00	1.15	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	40.55	4.14	0.59	0.00	0.30	2.07	0.30	0.59	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	6.78	0.00	0.00	0.00	1.69	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	82.43	3.31	0.41	0.00	0.83	1.24	1.66	2.90	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	49.02	1.84	2.99	0.46	1.84	0.23	1.15	1.15	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.05	3.08	1.15	0.38	1.54	0.00	1.15	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	58.35	2.61	0.65	0.00	0.65	1.30	0.98	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	36.12	4.01	0.00	0.00	0.00	2.01	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.10	6.16	1.16	0.77	0.39	1.54	0.00	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	93.80	9.24	3.42	0.00	2.05	1.37	1.71	1.71	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	22.36	0.00	0.00	0.00	2.48	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	51.43	6.61	0.47	0.00	0.94	0.94	0.47	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	52.50	4.83	0.60	0.00	0.60	1.21	0.00	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	79.35	7.63	1.02	0.00	0.51	1.53	0.51	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.20	2.39	0.40	0.00	0.00	0.40	1.20	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	62.66	5.92	1.48	0.00	0.00	0.99	0.99	1.97	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	68.47	8.26	0.00	0.00	0.00	1.18	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.34	3.50	0.00	0.00	1.17	0.00	0.58	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.47	6.14	0.00	0.00	0.44	0.00	1.32	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	69.51	2.54	0.00	0.00	0.85	0.85	1.70	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	66.85	4.78	1.79	0.60	1.79	1.19	1.19	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.55	1.94	0.97	0.49	0.00	1.46	0.49	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	2.28	0.00	0.00	1.14	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.50	2.91	0.83	1.25	0.42	2.49	0.83	1.66	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	33.73	4.50	0.00	0.00	1.12	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.13	2.54	0.00	0.00	0.32	0.32	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.62	1.67	0.00	0.00	0.00	0.84	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.44	0.46	0.00	12.76	0.00	0.00	0.12	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.70	0.34	0.00	14.01	0.00	0.00	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.73	0.68	0.00	11.38	0.00	0.00	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.06	0.11	0.00	13.44	0.00	0.00	0.00	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.36	0.21	0.00	13.32	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.23	0.22	0.00	9.69	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.24	0.00	0.00	6.85	0.00	0.00	0.00	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1.20	0.00	0.00	7.38	0.00	0.00	0.00	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.60	0.00	0.00	7.05	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	2.80	1.68	0.00	4.48	0.56	0.56	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	21.21	3.46	0.43	0.00	1.73	0.00	0.00	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	49.38	4.94	0.00	2.12	0.00	1.41	0.00	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	34.15	5.09	0.00	0.00	0.00	0.73	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.11	1.57	0.35	0.35	0.00	0.35	0.00	1.05	0.52
Hepatocyte, donor1	11523-119I2	66.58	14.53	0.00	0.00	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	73.26	16.16	0.00	0.00	0.00	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	54.60	7.36	0.61	0.00	0.00	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	11.10	5.87	1.31	0.00	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	65.89	5.59	0.00	0.35	0.17	0.70	0.52	0.87	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.90	2.47	0.14	0.41	0.14	0.82	0.14	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	9.55	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	11.08	0.00	0.00	0.00	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	15.02	0.00	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	15.38	0.00	0.00	0.00	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	38.98	14.62	0.00	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	11.67	0.00	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	37.06	14.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	4.43	0.00	0.00	0.00	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.86	5.04	0.00	0.00	0.00	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	37.12	4.64	0.00	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	38.76	8.40	0.00	0.00	0.00	1.29	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	9.66	0.00	0.00	0.00	1.61	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00	0.00	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	42.37	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	34.42	8.40	0.00	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	42.60	0.80	0.00	0.00	0.00	0.80	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	8.31	0.00	0.00	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	2.36	0.00	0.00	0.00	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	3.63	0.00	0.00	0.00	0.00	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	8.61	0.00	0.00	0.00	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	3.81	0.00	0.00	0.00	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	5.10	0.00	0.00	0.00	0.00	1.91	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	5.47	0.00	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	5.71	0.00	0.00	0.00	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.21	3.70	0.00	0.62	0.00	0.62	0.62	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	38.63	0.00	0.00	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	34.07	3.48	0.00	0.00	0.00	0.70	0.70	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	6.64	0.00	0.00	0.00	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	11.34	0.00	0.00	0.00	0.00	0.87	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	13.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	6.97	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	40.54	8.53	0.00	0.00	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	2.77	0.00	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	7.36	0.00	0.00	0.00	0.92	0.92	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	9.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	40.18	9.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.34	0.90	0.16	30.03	0.00	0.00	0.16	0.16	0.08
Keratinocyte - epidermal, donor2	11349-117G8	3.51	1.17	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.72	0.09	0.00	18.08	0.00	0.19	0.00	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	17.60	0.45	0.45	4.54	0.23	0.34	0.45	0.34	0.11
Keratocytes, donor1	11527-119I6	24.76	3.78	0.00	0.00	0.00	0.34	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	18.75	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	26.28	3.56	0.00	0.20	0.20	0.99	0.59	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	6.59	0.00	2.20	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	2.16	0.00	0.00	0.00	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	54.78	6.46	0.35	0.00	0.12	1.73	0.35	0.69	0.23
Lens Epithelial Cells, donor3	11690-122I7	21.49	2.22	0.10	0.00	0.20	0.50	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.39	4.15	0.36	0.00	0.12	1.30	0.12	0.36	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	28.47	3.91	0.28	0.00	0.56	0.00	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	39.35	5.19	0.47	0.00	0.31	0.16	0.79	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.82	3.76	0.00	0.00	0.00	0.54	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	37.50	4.10	0.00	0.32	0.32	0.32	0.63	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	31.81	4.42	0.11	0.43	0.11	0.86	0.43	0.97	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.65	1.64	0.00	0.00	0.00	0.00	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.79	5.06	0.00	0.25	0.51	0.25	0.25	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	38.14	5.07	0.28	0.14	0.14	0.56	0.70	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.11	4.35	0.79	0.00	0.40	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.63	3.30	0.00	0.00	0.00	0.58	0.58	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	29.99	3.70	0.37	0.00	0.37	0.19	0.37	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.36	3.83	0.35	0.00	0.00	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	29.10	3.58	0.00	0.00	0.00	0.24	0.72	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.96	6.04	0.27	0.00	0.14	0.82	0.14	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.49	6.16	0.00	0.00	0.00	0.00	0.31	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.32	3.43	0.00	0.00	0.31	0.31	0.31	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	47.76	6.59	0.73	0.00	0.73	0.55	0.55	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.24	4.94	0.00	0.00	0.33	0.99	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	32.51	2.64	0.00	0.00	0.59	0.88	0.29	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	40.08	3.98	0.00	0.00	0.50	0.25	0.75	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.79	7.27	0.00	0.00	0.48	1.45	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.55	6.19	0.27	0.00	0.00	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.69	3.94	0.30	0.00	0.76	0.45	0.61	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.66	2.59	0.00	0.00	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	31.62	5.65	0.00	0.21	0.63	0.21	1.05	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.13	5.41	0.00	0.00	0.45	1.05	0.30	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.02	4.13	0.00	0.00	0.00	0.69	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	29.16	2.82	0.00	0.19	0.00	0.38	0.19	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.54	2.65	0.00	0.11	0.21	0.32	0.42	0.64	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.47	4.85	0.97	0.00	0.48	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	25.80	7.61	0.33	0.00	0.33	0.33	0.33	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	34.19	4.58	0.25	0.00	0.62	0.50	0.37	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.46	4.44	0.00	0.00	0.37	0.74	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.98	4.20	0.00	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.95	3.44	0.41	0.00	0.27	0.14	0.27	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	30.56	3.22	0.00	0.32	0.00	0.00	0.32	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.04	4.56	0.30	0.00	0.30	1.52	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.27	3.50	0.00	0.28	0.28	0.28	0.42	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	4.98	0.36	0.00	1.07	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	31.03	2.42	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.32	3.73	0.00	0.31	0.00	0.16	0.31	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.65	2.86	0.36	0.36	0.00	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.46	4.57	0.65	0.00	0.33	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	27.07	4.71	0.24	0.00	0.00	0.24	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.50	3.96	0.62	0.00	0.37	1.24	0.62	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.03	3.33	0.00	0.00	0.00	0.26	0.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	20.59	3.28	0.30	0.00	0.00	0.30	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.01	3.07	2.30	0.00	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	1.48	1.48	0.00	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	33.43	3.39	0.85	0.42	1.27	0.42	1.69	2.96	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	1.41	0.70	0.00	0.00	0.70	1.41	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	3.74	1.87	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	1.55	1.03	0.52	0.00	0.00	1.55	1.55	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	5.95	1.19	0.00	0.00	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.71	3.85	1.13	0.00	0.23	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.00	2.04	0.58	0.58	0.87	0.29	0.58	0.58	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	2.25	1.35	0.00	1.35	0.90	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.88	2.44	1.63	0.14	2.03	1.08	0.27	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.62	4.62	1.03	0.00	0.00	0.51	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.47	3.88	0.35	0.35	1.76	0.00	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	4.00	0.67	0.00	0.67	0.00	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	29.54	3.06	0.00	0.51	1.53	1.53	2.55	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.88	3.20	0.80	0.27	0.27	0.80	0.27	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.43	4.35	1.13	0.00	1.32	0.19	0.76	0.94	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.32	4.91	0.61	0.00	0.00	0.61	1.23	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	31.80	0.82	0.82	0.00	1.63	2.45	0.00	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.28	2.92	2.29	1.25	2.08	0.83	0.62	1.46	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	22.70	2.80	1.68	0.00	0.84	0.00	1.12	0.84	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	1.03	1.03	0.00	0.00	1.03	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.97	2.61	0.58	0.58	1.74	0.58	1.74	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.54	2.09	2.09	0.30	0.60	0.90	0.90	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	3.87	1.11	0.55	2.77	0.55	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	39.24	5.66	4.24	0.35	1.77	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.40	2.95	0.00	0.00	0.74	0.00	0.74	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	6.91	0.00	0.00	0.00	1.15	2.30	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	30.32	6.52	0.77	0.00	1.54	1.15	0.77	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	29.44	4.53	0.00	0.00	1.13	0.00	2.26	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	2.46	0.82	0.00	0.00	1.64	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	35.70	4.07	0.00	0.45	0.45	0.00	1.81	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	2.15	0.00	0.00	0.00	0.00	0.72	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	2.24	0.75	0.00	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.38	4.83	1.11	0.74	1.86	0.74	0.74	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.09	2.58	1.72	0.86	0.43	0.00	0.43	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	1.71	0.00	0.00	0.00	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.65	4.66	1.00	0.67	0.67	0.67	0.33	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	37.41	4.83	0.00	0.60	1.81	0.00	0.60	0.00	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.28	4.98	0.00	0.00	0.71	2.13	1.42	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.81	3.78	1.03	0.34	0.69	0.69	1.72	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	29.52	3.76	1.61	0.00	0.54	0.54	1.07	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.99	5.39	0.67	0.00	1.35	1.35	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	44.08	5.19	0.74	0.00	0.37	0.00	1.11	1.48	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	4.65	2.33	0.00	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	43.37	4.23	0.00	0.00	3.17	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	49.62	8.00	1.20	0.40	1.60	0.00	1.60	2.00	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.80	2.18	0.73	0.00	1.45	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	42.16	6.90	0.77	0.77	1.53	2.30	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.12	3.95	2.47	0.99	3.45	1.48	1.97	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	4.70	0.94	0.00	0.94	0.00	1.88	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	33.19	4.02	3.02	0.00	0.50	0.50	1.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.56	4.06	1.80	1.35	2.25	0.90	4.51	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	3.44	1.72	1.72	0.00	0.00	1.72	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	3.12	1.34	0.00	1.34	1.34	1.34	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	30.89	5.08	1.56	0.78	1.56	0.78	2.74	0.00	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.09	3.96	0.66	0.00	1.32	0.00	0.66	0.00	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	25.95	6.75	2.08	0.00	0.52	0.00	1.56	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	39.82	4.38	2.63	0.88	2.19	1.31	3.50	2.63	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	1.68	0.00	0.56	1.68	1.12	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	5.30	0.88	0.00	2.21	2.65	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.33	6.56	1.93	0.77	1.93	0.00	3.09	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.38	5.06	1.52	0.51	0.51	0.51	2.53	1.01	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.03	5.29	1.44	0.96	0.96	0.96	0.48	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.97	10.73	1.19	0.80	0.40	0.40	0.80	1.59	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.99	1.22	1.22	0.61	1.82	0.00	0.61	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	5.53	0.69	1.38	0.00	0.69	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.20	5.32	2.66	0.76	1.14	1.90	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	2.07	0.00	0.52	1.03	0.00	0.52	2.58	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	6.65	1.81	0.60	0.00	0.60	1.21	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.20	7.29	1.90	0.32	0.95	0.32	0.63	0.63	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	35.72	8.00	1.60	0.00	0.53	0.53	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	37.35	5.75	1.15	0.00	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.05	6.69	1.03	1.54	3.09	1.03	1.54	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	36.78	2.83	0.71	0.71	2.12	0.71	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	38.59	6.24	1.13	0.57	1.13	0.57	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.02	9.98	2.91	0.00	1.25	1.25	2.08	0.83	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	37.59	5.48	0.78	0.00	1.57	0.00	2.35	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	27.98	5.01	1.67	0.42	1.67	0.84	0.42	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.06	6.50	1.86	0.00	1.86	0.93	0.46	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	30.11	6.02	0.00	0.00	2.68	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.82	5.88	0.00	0.00	1.60	1.60	1.60	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.99	4.85	1.62	0.00	1.21	2.42	2.42	0.81	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	4.59	0.00	0.00	0.00	0.92	3.67	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	5.33	0.89	0.89	1.78	2.67	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	40.46	7.41	2.28	0.00	2.85	1.14	1.14	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.21	3.83	0.77	0.00	2.30	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.02	10.40	0.55	0.00	1.64	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.30	4.90	0.45	0.00	1.78	1.34	2.23	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	41.59	4.42	1.30	0.26	2.86	0.78	0.52	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.18	7.96	0.66	0.66	2.65	0.00	0.66	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	6.24	4.16	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	61.08	16.18	1.37	0.23	3.65	0.23	1.37	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	30.28	9.18	4.22	0.55	5.32	0.55	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	40.64	10.36	1.44	0.26	7.47	0.39	1.97	0.92	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.12	0.00	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.57	0.63	0.16	0.00	0.00	0.00	0.00	0.63	0.16
Mallassez-derived cells, donor3	11930-125I4	9.17	0.28	0.69	0.00	0.00	0.14	0.56	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.97	0.90	0.00	0.10	0.00	0.10	0.20	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	12.16	1.16	0.00	0.00	0.00	0.00	0.00	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	14.22	1.75	0.25	0.00	0.25	0.50	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	21.02	3.39	0.00	2.03	0.00	0.00	2.03	0.00	1.36
Mast cell, donor1	11563-120D6	100.68	29.52	0.00	0.11	0.00	2.27	1.62	0.76	0.43
Mast cell, donor2	11565-120D8	166.71	35.96	2.08	0.00	5.05	2.97	3.86	0.30	0.30
Mast cell, donor3	11566-120D9	205.76	62.36	3.83	0.68	8.10	3.60	3.15	0.00	0.45
Mast cell, donor4	11567-120E1	150.87	30.85	1.95	0.53	2.30	3.37	2.30	0.89	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	86.05	17.19	0.67	0.33	0.11	0.67	0.89	0.78	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	137.17	18.09	0.00	0.58	0.58	0.58	1.75	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	95.10	17.67	0.11	0.11	0.00	0.92	0.92	0.46	0.57
Mast cell, expanded, donor8	11941-126A6	224.61	42.85	0.17	0.84	0.17	1.67	4.02	2.18	0.50
Melanocyte - dark, donor1	11502-119F8	19.90	1.89	0.70	0.00	2.19	0.20	0.30	0.20	0.30
Melanocyte - dark, donor2	11582-120F7	30.80	3.46	0.00	0.35	0.00	0.00	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	34.63	4.20	0.72	0.14	1.01	1.16	0.07	0.07	0.43
Melanocyte - light, donor1	11274-116H5	39.96	4.94	0.47	0.00	0.00	0.94	0.00	0.71	0.00
Melanocyte - light, donor2	11351-117H1	47.09	6.82	0.68	0.68	0.00	0.68	2.05	0.68	0.00
Melanocyte - light, donor3	11423-118G1	31.22	5.20	0.00	0.00	0.87	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.81	2.29	0.42	0.00	0.10	0.73	0.52	0.62	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	15.06	0.81	0.00	0.27	0.00	0.00	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	40.98	7.77	1.87	0.00	0.27	1.07	0.54	1.34	1.07
Meningeal Cells, donor1	11493-119E8	47.14	6.08	1.61	0.00	4.71	0.99	0.37	0.99	0.25
Meningeal Cells, donor2	11573-120E7	32.57	4.84	0.88	0.00	2.64	2.20	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	29.18	2.85	0.98	0.24	3.02	0.65	0.49	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	19.39	3.14	0.86	0.00	1.71	0.29	0.00	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	32.00	2.01	0.00	1.71	0.00	0.81	0.20	0.40	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	3.94	0.00	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	6.54	2.62	0.00	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	1.44	0.00	0.00	0.00	0.72	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.15	3.60	0.21	0.00	0.42	1.27	0.21	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	31.67	5.03	0.00	1.01	0.00	1.51	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.77	2.64	1.10	0.00	0.44	0.88	0.00	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	6.58	2.92	0.00	0.00	2.19	0.73	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	28.03	3.27	1.64	0.00	0.61	0.61	0.41	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.33	2.63	0.42	0.00	0.00	0.55	0.00	0.14	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	40.52	5.95	4.09	0.00	1.86	0.00	0.74	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.31	3.68	2.37	0.26	1.58	1.18	0.39	0.26	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	2.67	0.00	7.72	0.00	0.89	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	4.67	0.00	0.00	0.00	0.00	0.00	4.67	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.21	1.92	0.00	13.45	0.00	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.73	0.35	0.00	0.00	0.71	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.20	2.50	0.31	0.63	0.63	0.00	0.00	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	2.18	0.00	1.45	0.00	0.00	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	24.93	2.65	0.00	2.39	0.00	1.33	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	5.51	0.50	0.00	0.50	0.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	23.05	2.89	0.00	1.45	0.00	1.37	0.65	0.51	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	6.75	5.40	0.00	17.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	55.17	15.02	1.97	0.00	10.59	0.74	4.43	0.74	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.34	12.96	0.59	0.29	7.66	0.88	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	10.37	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.30	13.33	0.93	0.62	6.82	0.62	0.93	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.55	8.50	0.21	0.00	8.50	0.00	0.83	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	6.95	4.63	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	41.04	14.77	1.25	0.50	6.76	0.50	3.75	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.48	8.84	2.79	0.00	9.31	0.00	0.93	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	38.93	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.24	13.82	1.22	0.61	6.71	0.41	3.66	0.41	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.86	10.69	1.19	0.00	8.32	0.00	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	7.96	0.00	0.00	5.31	0.00	2.65	1.77	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	8.74	0.38	0.38	6.84	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	2.63	2.63	0.00	7.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	36.50	11.67	1.06	0.42	6.15	0.64	1.70	0.85	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	7.37	2.76	0.00	7.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	34.57	9.24	1.79	0.00	5.37	0.00	2.98	1.79	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	1.68	1.68	1.68	11.74	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	28.60	8.03	0.25	0.75	4.27	0.25	3.01	1.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.82	7.84	0.95	0.24	2.61	0.00	0.71	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	4.98	1.66	0.00	4.42	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.18	5.99	0.46	0.00	3.22	0.00	0.92	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.92	6.10	0.00	0.42	5.05	0.63	0.84	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.89	12.03	0.20	0.20	6.32	0.20	1.02	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.17	9.87	0.86	0.00	4.93	0.00	1.07	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.56	5.11	0.67	0.00	2.67	0.00	1.11	0.44	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.94	10.51	0.88	0.00	3.29	0.00	1.10	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	6.59	0.00	0.51	4.06	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.52	12.50	0.82	0.00	5.44	0.27	0.27	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	5.59	0.29	0.29	4.71	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	1.09	1.09	0.00	0.00	0.00	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.47	9.61	0.48	0.00	1.92	0.96	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.81	4.80	0.80	0.00	2.00	0.00	0.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	5.48	1.37	1.37	2.74	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.54	12.51	0.00	1.00	1.50	0.50	2.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	30.58	10.19	0.00	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	34.60	10.95	0.44	0.00	4.82	0.00	1.31	0.88	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	5.52	1.10	0.00	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.98	5.76	1.28	0.00	3.20	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	28.51	10.16	0.99	0.00	4.71	0.25	0.99	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.09	6.26	0.00	0.00	2.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	4.42	0.00	0.00	4.42	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.64	6.15	2.39	0.34	4.79	0.68	1.37	1.03	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.63	4.81	1.31	0.00	2.19	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.98	4.62	2.84	0.00	2.84	0.36	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.16	5.33	0.28	0.00	3.09	0.28	0.28	0.84	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.63	7.48	0.42	0.00	2.08	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	14.57	5.24	1.75	0.00	1.75	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.05	7.84	0.90	0.00	1.21	0.30	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	26.30	5.84	0.83	0.42	2.09	0.83	0.83	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	4.62	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	3.98	0.57	0.00	2.28	0.00	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.59	4.97	0.55	0.00	1.24	0.00	0.97	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.10	3.89	0.52	0.00	1.04	0.26	0.52	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.45	3.43	0.43	0.43	3.86	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.15	3.81	0.64	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.69	4.27	0.00	0.00	1.33	0.00	0.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.33	6.88	1.20	0.30	5.39	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.06	3.39	1.13	0.00	1.41	0.28	0.99	0.85	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.93	2.23	0.32	0.00	0.96	0.00	0.64	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	23.22	4.64	0.88	0.00	1.33	0.00	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.58	6.45	0.76	0.00	0.38	0.76	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	4.83	0.28	0.00	1.42	0.00	0.57	0.57	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.56	5.65	0.25	0.25	2.70	0.00	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	3.91	1.30	0.00	1.30	0.00	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.34	6.76	0.59	0.00	1.76	0.00	1.18	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.73	6.92	2.02	0.29	4.04	0.00	2.02	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	46.98	3.71	1.65	0.00	4.95	0.82	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	44.67	10.72	1.19	0.00	1.19	0.60	0.89	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	8.91	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	71.30	16.76	1.31	0.00	1.64	0.00	2.30	1.31	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	44.18	18.94	3.16	0.00	2.10	0.00	3.16	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	72.75	18.98	1.19	0.40	1.38	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	52.15	24.21	0.93	2.79	3.73	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.57	14.65	0.00	0.38	2.63	0.38	1.13	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	36.49	14.92	1.07	0.00	4.00	0.27	0.80	0.80	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.95	10.97	1.02	0.00	2.04	0.00	0.57	0.34	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	45.68	20.63	0.00	0.74	5.89	0.00	2.95	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.53	12.46	0.00	0.37	3.30	0.73	2.93	1.83	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	71.56	21.78	1.56	3.11	6.22	1.56	3.11	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.62	8.02	0.53	0.00	0.00	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	23.18	0.00	3.86	0.00	0.00	3.86	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	54.54	9.09	1.01	1.01	6.06	0.00	3.03	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	7.59	2.11	0.00	5.48	0.84	2.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	1.27	0.64	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	28.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	13.05	6.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	25.10	25.10	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.59	3.66	0.00	0.00	0.00	0.65	0.43	1.29	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	43.90	4.18	0.00	1.05	0.00	0.52	0.00	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	2.67	0.00	0.00	0.00	1.33	0.00	2.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.95	0.83	0.00	0.00	0.00	2.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	36.89	3.99	0.19	0.00	0.19	0.57	0.76	1.14	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	41.49	1.60	0.00	0.00	0.00	1.60	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	5.44	0.00	0.00	0.00	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	0.00	0.00	0.00	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	26.79	1.67	0.00	0.00	0.00	0.42	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.29	2.32	0.23	0.00	0.00	1.16	0.70	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.35	2.70	0.00	0.27	0.27	1.35	0.27	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.08	6.31	0.21	0.00	0.00	1.26	0.63	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	39.21	6.95	0.00	0.00	0.00	1.99	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.38	1.62	0.00	0.00	0.00	0.27	0.00	1.08	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.17	3.17	0.00	0.23	0.00	0.91	0.45	0.68	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	32.01	4.25	0.00	0.33	0.16	1.31	0.49	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	54.49	5.10	0.00	0.18	0.00	1.09	1.64	2.19	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	41.37	3.18	0.00	0.53	0.00	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	53.43	5.40	0.00	0.00	0.00	0.60	1.80	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.07	5.25	0.00	0.00	0.00	0.00	1.31	0.33	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.51	1.63	0.00	0.00	0.00	0.65	0.49	0.81	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.56	6.88	0.00	0.00	0.00	1.76	1.23	0.88	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	39.38	4.92	0.00	0.70	0.00	0.00	2.11	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	49.65	5.06	0.46	0.00	0.00	1.84	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	33.10	3.86	0.00	0.00	0.00	0.64	0.32	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.52	2.76	0.00	0.69	0.00	0.00	0.69	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	0.00	0.00	2.53	0.00	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.01	4.23	0.45	0.00	0.00	2.67	0.45	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	49.11	3.81	0.00	0.00	0.00	1.27	0.85	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.86	4.51	0.00	0.24	0.00	1.66	0.71	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.04	3.43	0.00	0.43	0.00	0.00	0.86	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.99	3.33	0.00	0.00	0.00	1.67	0.33	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	40.13	5.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.19	2.38	0.00	0.40	0.00	0.79	0.40	1.98	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	42.72	6.50	0.00	0.00	0.00	0.93	0.93	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	38.22	4.92	0.00	0.00	0.38	3.41	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.88	2.61	0.00	0.33	0.00	0.65	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	47.94	5.23	0.00	0.00	0.00	1.74	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	36.18	3.17	0.45	0.00	0.00	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	2.65	0.00	0.00	0.00	1.76	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	43.88	3.32	0.00	0.00	0.00	1.99	1.99	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	42.16	4.46	0.50	0.50	0.00	1.98	0.99	0.99	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.88	2.30	0.00	0.00	0.00	0.77	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	81.66	5.75	0.00	0.00	0.00	3.02	0.91	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	41.77	2.21	0.00	0.00	0.00	1.11	0.22	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	5.42	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	43.90	4.88	0.00	0.00	0.00	1.83	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.86	4.72	0.00	0.00	0.00	1.57	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.36	5.45	0.00	0.91	0.00	0.61	0.61	1.82	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	25.32	2.37	0.00	0.00	0.00	0.00	1.58	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	3.40	0.00	2.27	0.00	0.00	3.40	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	14.91	2.86	0.00	0.00	0.12	0.25	0.12	0.12	0.00
Myoblast, donor2	11322-117D8	52.93	5.37	1.53	0.77	0.96	1.34	1.15	2.69	1.34
Myoblast, donor3	11398-118D3	35.15	6.05	0.84	0.17	0.17	1.51	0.00	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	1.46	0.44	6.13	0.29	3.06	0.00	0.44	0.29	0.58
Natural Killer Cells, donor1	11230-116C6	35.67	17.22	2.46	0.31	0.92	0.00	0.31	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	27.74	9.95	1.81	1.81	0.00	0.30	2.11	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	33.68	12.15	3.31	1.29	0.74	0.37	0.18	0.55	0.18
Neural stem cells, donor1	11275-116H6	209.42	22.14	7.62	1.45	1.09	2.18	6.17	0.36	1.09
Neural stem cells, donor2	11352-117H2	136.72	30.81	71.25	1.93	48.14	7.70	5.78	1.93	0.00
Neurons, donor1	11494-119E9	129.72	61.45	28.45	0.00	7.97	0.00	4.55	2.28	0.00
Neurons, donor2	11574-120E8	38.09	15.85	26.42	0.66	9.69	0.88	1.98	0.22	1.54
Neurons, donor3	11655-122E8	75.64	34.53	23.84	0.82	8.22	0.82	5.76	5.76	4.11
Neutrophils, donor1	11233-116C9	91.87	45.47	4.64	0.00	17.63	0.93	7.42	3.71	0.93
Neutrophils, donor2	11314-117C9	133.35	72.47	20.29	5.80	17.39	0.00	11.60	14.49	14.49
Neutrophils, donor3	11390-118C4	130.11	65.36	8.55	0.00	8.55	1.83	6.11	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	51.29	6.77	0.95	1.66	0.71	1.19	0.36	0.95	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	26.37	2.93	1.30	0.00	0.65	0.98	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.65	2.81	0.40	0.00	0.20	0.60	0.20	0.20	0.80
Olfactory epithelial cells, donor1	11933-125I7	31.80	2.48	0.28	0.00	0.00	0.41	0.83	1.93	0.69
Olfactory epithelial cells, donor2	11934-125I8	29.09	2.03	0.00	0.29	0.00	0.87	2.32	3.04	1.01
Olfactory epithelial cells, donor3	11935-125I9	21.57	1.82	0.00	0.00	0.11	0.68	0.23	0.45	0.57
Olfactory epithelial cells, donor4	11936-126A1	29.51	2.05	0.00	0.00	0.00	0.19	0.58	0.49	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	27.08	4.21	0.60	0.60	0.00	1.81	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	29.78	1.70	0.00	0.00	0.00	0.43	0.85	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	30.86	2.29	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.90	2.48	1.24	0.00	0.62	0.62	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	61.76	5.28	0.00	0.00	0.00	2.35	0.20	0.98	0.00
Osteoblast, donor2	11354-117H4	46.35	4.21	0.00	0.00	0.70	2.11	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	54.03	4.09	0.53	0.18	0.00	2.84	0.71	1.78	0.36
Pancreatic stromal cells, donor1	11249-116E7	26.96	2.27	0.08	0.08	0.08	0.76	0.08	0.42	0.17
Pericytes, donor1	11491-119E6	42.39	8.01	1.67	0.45	6.23	0.45	0.67	0.22	0.56
Pericytes, donor2	11571-120E5	31.69	6.79	1.36	0.45	4.98	1.58	0.91	0.68	0.23
Pericytes, donor3	11652-122E5	16.68	1.83	0.00	0.00	0.00	0.61	1.02	0.20	0.00
Perineurial Cells, donor1	11499-119F5	16.95	1.47	0.00	0.11	0.00	1.02	0.00	0.23	0.00
Perineurial Cells, donor2	11579-120F4	26.87	1.29	0.09	0.09	0.09	1.47	0.00	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	79.68	21.36	3.82	0.64	2.87	0.00	0.00	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	89.86	20.32	2.94	0.24	3.18	0.49	2.69	2.69	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	58.24	20.84	5.82	0.00	2.98	0.39	0.91	1.16	0.78
Placental Epithelial Cells, donor1	11278-116H9	6.46	0.72	0.24	0.00	0.48	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	7.76	1.11	0.00	0.00	1.11	0.00	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.23	0.59	0.00	0.20	0.00	0.00	0.00	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.43	1.27	0.00	0.63	0.00	0.63	2.22	3.48	0.63
Preadipocyte - breast, donor1	11467-119B9	56.65	4.50	0.00	0.75	0.00	0.19	1.31	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	78.84	7.31	0.13	0.65	0.00	3.79	0.52	0.52	0.52
Preadipocyte - breast, donor2	11328-117E5	70.92	4.73	0.00	0.90	0.00	0.90	2.25	3.15	0.90
Preadipocyte - omental, donor1	11468-119C1	67.98	4.16	0.00	0.32	0.00	0.96	0.64	0.85	0.00
Preadipocyte - omental, donor2	11329-117E6	44.52	3.06	0.00	0.44	0.00	0.87	1.75	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	47.85	6.59	0.00	1.43	0.00	2.44	1.15	1.58	0.43
Preadipocyte - perirenal, donor1	11469-119C2	33.47	8.86	0.00	0.00	0.00	0.00	0.00	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	41.46	4.30	0.00	0.00	0.00	0.92	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	44.80	3.90	0.35	0.53	0.35	1.95	2.30	2.83	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	35.08	2.89	0.00	0.00	0.34	1.53	0.51	1.70	0.68
Preadipocyte - visceral, donor1	11280-116I2	37.91	2.70	0.28	0.19	0.28	0.65	0.37	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	33.59	2.30	0.00	0.46	0.00	0.00	0.46	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	25.81	2.61	0.42	0.00	0.00	0.94	0.84	1.57	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.52	4.37	0.00	0.00	0.00	0.60	0.30	0.91	0.30
Prostate Epithelial Cells, donor2	11331-117E8	9.48	0.68	0.14	0.00	0.27	0.00	0.41	0.95	0.27
Prostate Epithelial Cells, donor3	11404-118D9	18.25	1.71	0.24	0.24	0.06	0.43	0.43	0.37	0.18
Prostate Stromal Cells, donor1	11254-116F3	28.02	2.51	0.23	0.11	0.11	1.82	0.23	0.80	0.23
Prostate Stromal Cells, donor2	11332-117E9	37.65	2.87	0.00	0.18	0.36	1.08	2.15	2.33	1.26
Prostate Stromal Cells, donor3	11405-118E1	35.87	3.02	0.00	0.31	0.00	1.15	0.52	1.04	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.93	2.92	0.00	0.00	0.00	1.46	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.73	1.94	0.07	0.21	0.00	0.83	0.21	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	37.54	4.06	1.52	0.00	0.51	1.52	0.00	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	30.59	0.71	0.71	0.00	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	26.89	1.38	0.32	0.32	0.00	0.85	0.42	0.53	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	20.43	1.36	2.04	0.00	0.68	0.00	0.68	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.44	2.43	1.35	0.00	1.35	0.40	0.54	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.76	4.00	0.67	0.00	0.44	0.89	0.22	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	30.61	2.66	0.00	0.00	1.33	0.67	0.00	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	39.18	3.74	0.22	0.00	0.22	2.42	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	42.63	3.76	0.00	0.00	0.00	0.00	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	36.06	7.49	0.00	0.00	0.00	1.66	0.28	1.39	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.23	0.81	1.07	0.00	0.27	0.00	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	0.84	0.42	0.00	0.00	0.42	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.21	2.12	0.58	0.00	0.00	2.12	0.39	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	20.22	4.15	1.04	0.00	0.00	0.52	0.26	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.36	6.54	0.85	0.85	0.00	0.57	0.00	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	32.93	0.00	2.06	0.00	0.00	0.00	2.06	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.35	2.26	1.25	0.00	0.00	0.00	0.25	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.04	12.16	1.07	0.13	1.07	1.47	0.27	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	80.41	12.51	0.00	0.00	0.00	0.00	1.79	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	112.28	24.77	0.00	1.65	0.00	0.00	4.40	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	93.97	24.94	0.00	0.58	0.00	0.00	0.58	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	61.37	8.45	0.00	0.13	0.00	0.78	0.78	0.39	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	80.14	9.14	0.00	0.20	0.00	1.59	1.29	2.38	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.52	10.04	0.00	0.22	0.00	1.00	0.22	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	72.44	11.54	0.00	0.25	0.00	1.24	0.74	1.86	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	75.05	11.42	0.00	0.93	0.00	1.52	1.05	3.26	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	93.38	12.48	0.00	0.23	0.00	0.92	0.92	0.69	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	74.20	10.68	0.00	0.41	0.00	1.10	0.14	2.05	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	80.93	9.53	0.00	0.15	0.00	1.82	3.33	4.54	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	70.06	9.14	0.00	0.36	0.00	1.25	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	76.61	13.48	0.00	0.72	0.00	1.58	0.57	1.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	74.80	9.44	0.00	0.43	0.00	0.75	1.40	2.47	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	75.90	9.07	0.00	0.22	0.00	1.11	0.44	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	88.13	10.90	0.00	0.38	0.00	1.34	0.96	1.72	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	71.08	9.13	0.09	0.00	0.00	2.05	0.75	1.86	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	85.69	10.15	0.00	0.00	0.00	1.13	0.75	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	70.60	8.63	0.00	0.27	0.00	2.52	0.13	0.66	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	82.64	12.65	0.10	0.49	0.00	1.56	2.04	1.56	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	77.91	11.84	0.00	0.38	0.00	2.10	0.57	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.21	10.36	0.00	0.43	0.00	1.71	0.53	0.85	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	91.66	5.61	0.00	0.00	0.00	0.84	1.68	3.08	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	83.06	8.72	0.00	0.34	0.00	0.85	0.68	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.26	7.84	0.00	0.73	0.00	0.36	0.36	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	87.07	9.44	0.00	0.37	0.00	0.98	0.86	1.72	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	83.82	9.27	0.00	0.13	0.00	1.48	0.81	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	88.45	10.14	0.00	0.47	0.00	0.47	0.71	1.89	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	64.68	10.12	0.00	0.40	0.00	2.38	2.78	2.98	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	78.10	9.59	0.00	0.00	0.00	1.17	0.47	1.64	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	65.52	8.09	0.00	0.00	0.00	0.83	0.41	1.24	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	78.09	5.53	0.00	0.66	0.00	0.44	2.21	3.54	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	75.20	7.52	0.00	0.00	0.21	0.84	0.42	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.60	9.29	0.00	0.40	0.00	2.56	0.67	0.81	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	71.18	10.56	0.00	0.17	0.00	2.04	0.68	1.19	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	76.54	10.80	0.00	0.00	0.00	1.54	0.58	1.16	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	86.83	12.55	0.00	0.17	0.00	0.86	0.17	0.86	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	67.76	7.96	0.00	0.41	0.00	1.23	0.27	0.69	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	75.03	9.52	0.00	0.00	0.00	1.31	0.82	0.66	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	86.07	10.40	0.00	0.34	0.00	2.22	0.68	1.36	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.51	7.99	0.00	0.15	0.00	1.63	0.44	1.04	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	87.43	9.06	0.00	0.00	0.00	0.80	0.80	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	78.81	14.38	0.00	0.14	0.00	1.52	0.28	1.24	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	60.24	7.38	0.00	0.24	0.00	1.67	0.24	0.95	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	120.92	17.94	0.00	0.00	0.00	2.02	0.81	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	69.03	11.96	0.00	0.09	0.00	0.94	0.75	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	88.39	16.42	0.00	0.70	0.00	0.35	1.75	1.05	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	89.15	13.30	0.00	0.60	0.00	1.81	0.91	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	68.90	13.95	0.00	0.49	0.00	1.96	0.73	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	229.39	42.21	0.00	0.15	0.00	3.06	1.02	1.46	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	108.91	15.21	0.00	0.61	0.00	1.22	1.22	3.65	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	62.69	13.86	0.00	0.00	0.00	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	105.18	13.35	0.00	0.45	0.00	0.68	2.04	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	128.80	26.06	0.00	0.60	0.00	1.50	1.50	1.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	78.64	14.88	0.00	0.24	0.00	1.65	2.13	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	111.42	17.93	0.21	0.43	0.00	1.07	4.06	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	123.80	25.84	0.00	0.00	0.00	1.20	3.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	39.12	4.70	0.19	0.38	0.38	0.94	0.75	1.32	0.38
Schwann Cells, donor2	11578-120F3	20.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	38.56	3.72	0.22	0.00	0.22	0.44	1.10	1.31	0.66
Sebocyte, donor1	11220-116B5	20.27	1.10	2.19	0.00	0.55	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	9.65	2.76	0.00	2.30	0.00	0.92	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	29.27	1.86	0.00	6.60	0.00	0.82	0.82	0.00	0.21
Sertoli Cells, donor1	11255-116F4	33.13	3.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	62.14	2.82	0.00	0.00	2.82	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	50.76	5.81	0.00	0.18	0.09	1.06	0.53	0.35	0.26
Skeletal Muscle Cells, donor2	11358-117H8	15.90	2.89	0.00	0.00	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	45.15	5.85	0.84	0.00	0.00	4.18	0.00	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	17.91	2.51	1.57	0.00	1.26	0.31	0.31	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	18.43	2.08	0.89	0.00	0.45	0.89	0.59	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	14.93	1.69	0.46	0.00	0.31	0.77	0.31	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.23	2.39	0.50	0.13	0.38	0.63	0.38	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.97	2.85	1.14	0.14	0.57	0.86	0.86	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.62	2.28	1.19	0.10	0.99	0.99	0.40	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.03	2.86	0.00	0.00	0.00	0.42	0.00	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	1.45	0.00	0.00	0.00	3.62	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	39.49	3.16	0.14	0.00	0.14	2.20	0.69	1.79	0.55
Skin - palm, donor1	10286-104F7	145.05	21.49	0.00	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.20	1.01	0.00	0.00	0.14	0.14	0.29	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.98	7.36	0.00	0.00	0.00	0.00	1.64	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.27	0.52	0.26	0.00	0.00	0.13	0.13	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	11.54	0.97	0.14	0.00	0.00	0.00	0.28	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	11.96	0.98	0.14	0.14	0.14	0.84	0.42	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	46.10	6.13	0.00	0.00	0.21	2.75	0.00	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	16.11	1.80	0.22	0.15	0.22	0.52	0.30	0.37	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.30	2.47	0.00	0.00	0.00	0.62	0.00	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.14	6.23	0.00	0.67	0.44	2.22	0.44	1.33	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	50.55	1.18	0.00	0.00	0.00	4.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	84.42	7.96	0.00	0.22	0.00	1.33	0.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.54	1.58	0.00	0.00	0.00	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	47.90	3.09	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	46.03	7.01	0.00	1.00	0.00	0.00	1.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.08	2.40	0.13	0.00	0.00	1.86	0.13	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.38	1.77	0.22	0.22	0.22	0.22	0.89	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.74	0.64	0.13	0.00	0.13	0.13	0.00	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.05	0.98	0.00	0.00	0.65	0.65	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.01	3.25	0.30	0.30	0.89	0.59	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.24	1.42	0.43	0.00	0.14	0.57	0.00	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	17.89	2.28	0.49	0.00	0.16	0.49	0.00	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.40	3.35	0.00	0.00	0.30	0.91	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	50.51	2.53	0.51	0.51	0.00	1.52	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	0.48	0.48	0.48	0.00	0.95	0.00	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.91	1.18	0.00	0.15	0.00	0.74	0.44	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.49	2.80	0.43	0.00	0.00	0.43	0.43	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.73	2.10	0.21	0.10	0.31	0.52	0.00	0.31	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.71	1.39	0.00	0.00	0.15	0.62	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	0.00	0.00	0.00	0.00	2.16	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.14	1.20	0.00	0.00	0.00	1.20	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.63	1.37	0.68	0.34	1.02	0.68	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.97	2.59	0.08	0.00	0.24	0.47	0.31	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	38.95	5.43	0.70	0.40	1.01	0.91	1.31	0.30	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	26.40	2.50	0.00	0.46	0.00	0.46	0.91	0.23	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	26.57	1.81	0.00	0.60	0.00	1.21	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.49	1.32	0.53	0.00	0.26	0.26	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.75	4.93	0.13	0.67	0.00	1.07	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.32	4.01	0.00	0.25	0.13	0.75	1.38	0.50	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.40	2.79	0.51	0.00	0.76	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	44.33	3.02	0.15	0.00	0.00	1.81	0.15	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	39.01	2.25	0.00	0.00	0.00	0.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	337.27	37.47	0.00	6.46	0.00	0.00	3.88	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	73.95	5.12	0.00	0.00	0.00	2.33	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.23	2.52	1.01	0.00	0.00	1.51	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.67	0.94	0.00	0.00	0.00	0.31	0.94	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.57	1.47	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.08	1.50	0.08	0.00	0.25	0.83	0.08	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	2.80	0.47	0.00	0.93	0.47	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.94	1.73	0.29	0.14	0.14	0.29	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	2.04	0.76	0.25	0.25	0.51	0.00	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	13.91	0.75	0.00	0.00	0.00	1.69	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	17.19	0.98	0.00	5.45	0.00	0.84	0.56	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.22	1.01	0.00	3.35	0.00	0.59	0.08	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	30.48	3.33	0.00	5.24	0.00	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.79	0.98	0.98	0.00	0.00	1.47	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	16.79	2.21	0.22	0.22	0.44	1.99	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	32.77	2.34	0.00	0.00	0.29	0.88	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.48	6.41	0.00	0.39	0.00	0.97	0.97	0.78	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.79	2.91	0.00	0.00	0.00	0.26	2.12	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.99	4.09	0.00	0.37	0.00	0.00	1.86	1.12	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.42	5.75	0.00	0.00	0.00	0.00	0.36	2.16	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	38.61	6.25	0.00	0.28	0.00	0.28	0.57	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.51	3.15	0.00	0.79	0.00	0.00	0.39	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	43.68	4.06	0.00	0.51	0.00	0.51	1.27	1.78	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	40.73	3.59	0.00	0.00	0.00	0.40	0.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	35.53	3.76	0.00	0.42	0.42	0.84	0.42	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	40.34	5.04	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	36.19	2.19	0.67	0.34	0.50	0.67	1.35	0.34	0.17
Synoviocyte, donor2	11368-117I9	60.85	3.35	0.17	0.67	0.00	1.84	1.01	2.01	1.01
Synoviocyte, donor3	11440-118H9	31.72	2.68	0.00	0.67	0.00	2.23	0.89	1.56	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	36.45	2.14	1.07	1.43	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	29.17	2.78	0.46	0.23	0.23	0.46	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.32	0.86	0.14	0.36	0.00	0.00	0.07	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	0.77	0.39	0.00	0.39	1.16	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	44.66	12.06	0.86	0.25	1.11	1.60	1.35	0.86	0.37
Urethra, donor2	10319-105A4	97.12	7.19	0.00	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.95	2.13	0.00	0.27	0.27	0.27	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	13.62	2.00	0.00	0.00	0.00	0.40	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	22.69	0.92	0.23	0.00	0.00	0.46	0.23	0.92	0.00
Urothelial cells, donor0	11216-116B1	16.49	0.45	0.00	0.00	0.00	0.22	0.22	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	60.51	30.25	0.00	0.00	1.78	0.00	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	75.77	61.47	0.00	1.43	0.00	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.08	28.75	2.05	0.68	2.05	0.00	0.68	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	51.65	28.92	0.34	0.34	2.07	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	55.20	24.98	0.58	0.58	2.32	0.00	0.58	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	62.47	40.61	1.04	1.04	3.12	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	65.16	36.71	1.84	0.92	4.59	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	68.47	39.25	0.91	0.00	0.91	0.00	1.83	3.65	1.83
Wilms' tumor cell line:G-401	10809-111A8	13.32	2.34	0.00	0.12	0.00	0.49	0.00	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	9.68	2.64	0.00	0.00	0.00	0.00	0.00	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	20.39	1.96	0.28	0.00	0.28	1.40	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	70.26	10.33	6.20	0.00	2.07	4.13	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	2.55	15.81	0.51	8.16	0.00	1.02	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	33.90	3.48	1.63	0.00	7.43	0.93	0.00	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	78.23	18.87	0.00	0.12	0.00	1.31	0.24	0.83	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	17.14	14.42	2.18	0.00	8.71	0.27	0.82	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	129.86	24.45	0.84	0.28	3.65	0.56	1.69	3.37	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	183.14	48.43	0.42	0.42	1.90	1.27	1.27	1.69	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	158.97	38.65	2.18	0.54	5.72	1.91	2.99	2.99	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	58.60	5.73	0.44	0.44	0.88	1.32	0.88	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	195.60	98.01	0.41	0.82	0.41	1.23	5.31	4.49	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	130.47	39.22	5.82	0.78	11.65	3.88	1.16	3.11	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.85	6.07	1.66	0.18	4.23	0.18	1.47	0.37	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	128.72	19.50	0.00	0.00	0.00	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	83.19	9.99	0.93	1.16	4.42	0.70	1.63	0.46	2.56
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	105.11	25.89	0.00	0.26	0.00	1.55	1.04	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	69.85	16.66	0.00	0.29	0.00	0.00	1.46	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.03	2.32	0.00	0.00	0.00	0.00	1.39	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.08	6.58	0.82	0.00	2.06	0.41	1.23	0.41	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.64	3.07	0.00	0.00	0.00	0.00	0.61	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	7.68	0.00	0.00	0.00	0.00	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	40.03	8.49	0.00	0.00	0.00	0.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.61	5.54	0.00	0.00	0.00	0.96	0.48	0.24	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.92	3.56	2.45	0.22	1.56	0.00	0.67	0.22	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	30.02	6.34	0.00	0.00	0.00	0.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	3.72	0.00	0.00	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	92.28	16.57	0.00	0.38	0.00	0.38	0.75	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	98.57	51.90	0.00	0.87	0.00	0.00	0.87	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	5.62	0.00	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	16.01	1.65	0.00	0.00	0.00	0.71	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	79.42	10.24	0.93	0.00	1.71	0.93	1.09	0.47	0.47
adipose, donor1	10184-103D4	42.22	9.38	3.52	1.17	0.00	0.59	1.76	0.59	2.35
adipose, donor2	10185-103D5	78.26	23.11	3.24	0.00	2.43	1.22	2.03	0.00	0.00
adipose, donor3	10186-103D6	140.23	26.68	5.72	1.36	1.36	2.45	1.63	0.54	0.27
adipose, donor4	10187-103D7	375.30	81.47	6.07	3.47	3.47	1.73	3.47	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.41	7.26	0.32	0.00	0.16	0.16	0.00	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	61.84	7.28	0.00	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.55	18.41	2.53	0.40	1.20	0.13	0.53	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.01	1.43	0.00	0.00	0.00	0.00	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	25.97	1.85	0.23	2.09	0.00	0.70	0.70	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	31.44	5.75	1.69	0.34	1.01	0.00	1.01	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	30.05	1.77	0.00	11.49	0.29	1.47	0.59	0.59	0.59
amygdala - adult, donor10196	10167-103B5	33.20	9.49	5.93	13.04	11.86	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	67.12	17.84	9.94	8.92	11.96	1.82	1.62	1.82	1.82
amygdala, newborn, donor10223	10360-105E9	40.02	13.56	8.07	1.29	14.85	0.97	0.65	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	16.30	3.18	0.00	0.00	0.00	0.76	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.44	0.44	5.96	0.00	2.65	0.00	0.22	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	85.85	8.35	0.00	0.00	0.33	4.01	0.33	0.67	0.67
aorta, adult, pool1	10052-101G7	76.10	11.38	1.37	0.20	0.59	2.35	0.78	0.98	0.00
appendix, adult	10189-103D9	50.84	6.60	5.82	0.39	8.15	0.78	1.94	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.18	8.60	0.00	0.34	0.00	0.69	0.00	1.03	0.34
artery, adult	10190-103E1	74.73	10.87	0.00	1.36	0.00	1.36	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	41.00	2.61	0.00	0.00	0.00	1.16	0.58	0.72	0.29
b cell line:RPMI1788	10427-106D4	13.53	6.99	3.12	0.00	4.01	0.00	0.45	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.32	2.50	0.00	0.00	0.00	0.83	1.11	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.43	1.49	0.00	0.00	0.00	0.69	0.30	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	24.77	1.51	0.00	0.00	0.00	0.67	0.33	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	52.01	10.07	0.56	0.00	1.12	0.56	0.00	0.56	0.56
bladder, adult, pool1	10011-101C2	78.11	13.25	0.54	0.76	0.65	2.06	2.28	1.09	0.98
blood, adult, pool1	10053-101G8	13.29	2.21	0.00	0.00	2.21	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	3.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	53.99	9.45	1.35	0.00	2.70	0.67	3.37	5.40	0.67
brain, adult, donor1	10084-102B3	47.15	15.38	11.28	10.25	7.18	1.03	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	39.75	13.81	12.81	23.61	6.79	1.00	2.23	0.89	0.89
brain, fetal, pool1	10085-102B4	64.11	32.06	37.40	0.00	34.73	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	23.79	2.97	4.96	1.32	2.97	0.66	1.98	0.00	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	50.80	9.49	4.12	0.12	2.25	1.00	0.75	0.12	0.37
breast, adult, donor1	10080-102A8	60.61	11.36	0.00	0.00	0.00	1.89	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	18.17	0.76	0.00	25.03	0.00	3.18	0.38	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	24.43	2.78	0.00	0.00	0.00	0.62	0.93	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1.61	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.04	0.48	3.63	0.73	1.94	0.00	0.00	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	10.81	4.70	29.62	0.00	0.47	0.47	2.35	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	17.94	3.39	0.00	0.22	0.00	0.55	0.11	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	11.73	4.12	0.00	0.32	0.00	0.32	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.51	19.43	4.53	0.80	7.72	0.00	1.60	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	44.90	13.82	8.06	2.30	5.76	1.15	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	57.06	17.40	8.87	0.50	3.68	1.51	0.84	0.84	1.17
caudate nucleus, adult, donor10258	10379-105H1	30.57	10.70	2.29	0.76	0.76	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	68.12	13.55	5.49	1.46	11.72	0.73	1.83	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	136.92	78.66	2.91	2.91	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	202.19	106.11	1.71	0.85	1.49	2.99	3.84	4.70	4.91
cerebellum, adult, pool1	10083-102B2	72.44	41.39	1.72	0.00	0.34	0.69	0.34	0.00	1.03
cerebellum, newborn, donor10223	10357-105E6	352.04	160.25	4.98	0.00	4.15	0.00	0.83	2.49	0.83
cerebral meninges, adult	10188-103D8	29.50	9.33	7.06	15.38	5.55	1.51	1.01	0.00	1.01
cerebrospinal fluid, donor2	10294-104G6	32.16	2.92	2.19	0.73	0.00	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	5.32	0.29	0.00	43.13	0.00	0.14	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	53.53	5.97	0.00	0.50	0.00	1.33	0.50	0.50	0.00
cervix, adult, pool1	10013-101C4	179.32	20.05	1.15	0.21	0.94	4.51	2.83	1.99	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.17	2.09	0.00	0.00	0.00	1.25	0.28	1.11	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	1.31	0.00	0.00	0.00	5.23	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	8.95	1.24	2.11	0.37	0.25	0.12	0.12	0.00	0.25
choriocarcinoma cell line:SCH	10785-110H2	6.65	0.37	0.62	0.00	0.49	0.12	0.00	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	7.35	0.24	1.90	0.00	1.66	0.00	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	11.11	0.85	1.14	1.42	0.28	0.85	0.57	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	27.64	1.89	0.20	0.40	0.20	1.59	1.09	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	14.84	2.20	0.00	0.55	0.55	0.55	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	5.05	0.00	0.00	2.02	0.00	2.02	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	71.27	12.68	0.19	0.00	0.00	1.15	0.38	0.77	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	28.93	6.12	0.00	0.00	0.00	0.63	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	26.96	10.53	0.00	0.26	0.00	0.00	0.00	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	33.14	9.43	0.00	0.00	0.00	0.48	0.24	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	44.79	9.57	0.00	0.20	0.00	0.61	0.61	0.81	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	20.61	2.36	0.00	0.00	0.00	0.00	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	67.24	16.68	0.00	0.00	0.00	0.78	0.26	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.69	1.37	0.00	0.46	0.00	0.46	0.46	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	2.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	25.99	2.38	0.00	0.00	0.00	0.55	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	11.78	3.04	0.00	0.00	0.00	0.76	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	105.91	21.42	2.38	0.00	0.00	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	75.20	13.04	2.47	0.71	0.59	2.00	1.65	0.59	0.24
colon, fetal, donor1	10070-101I7	55.62	3.71	3.09	3.09	3.71	0.62	2.47	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	797.53	215.43	4.58	0.00	0.00	18.33	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.92	5.95	5.10	0.00	2.55	0.42	1.27	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	15.70	1.96	4.83	0.15	6.94	0.15	1.51	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	21.29	3.38	5.64	0.28	7.19	0.56	0.42	0.00	0.85
corpus callosum, adult, pool1	10042-101F6	96.96	36.37	14.26	12.60	4.09	2.10	0.33	0.22	0.66
cruciate ligament, donor2	10295-104G7	116.71	10.54	3.24	2.43	2.43	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	59.39	7.22	0.00	0.00	0.00	2.41	0.00	0.00	0.80
diencephalon, adult	10193-103E4	34.08	9.60	3.36	2.64	2.40	0.72	0.72	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.70	1.15	2.07	0.00	3.44	0.00	1.15	1.15	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	1.28	0.00	1.54	0.00	1.03	0.00	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.13	1.69	0.00	0.00	0.00	0.72	0.48	0.00	0.00
ductus deferens, adult	10196-103E7	102.16	8.97	16.94	2.49	1.50	1.50	3.49	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	7.20	0.00	1.44	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	97.84	22.81	0.74	2.94	0.00	0.74	5.89	4.41	1.47
dura mater, adult, donor1	10041-101F5	107.45	26.35	6.11	0.17	4.46	3.80	1.49	1.24	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	3.55	0.67	0.44	0.00	0.22	0.44	0.22	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.76	1.72	0.57	0.14	1.00	0.00	0.14	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	156.00	10.48	0.00	0.62	0.00	5.55	1.23	3.70	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	116.54	11.50	0.00	0.91	0.00	3.94	2.72	3.94	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	161.48	12.04	0.00	0.31	0.00	4.01	1.23	2.16	0.93
embryonic pancreas cell line:2C6	10603-108E9	161.56	22.33	0.00	0.00	0.00	10.51	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.44	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	41.32	5.44	0.00	0.00	0.00	1.63	0.36	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.09	0.96	0.00	0.32	0.00	0.48	0.48	0.96	0.16
epidermoid carcinoma cell line:A431	10426-106D3	57.25	2.67	0.00	0.22	0.00	1.67	0.67	0.78	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.27	0.33	0.00	0.00	0.11	0.66	0.00	0.00	0.11
epididymis, adult	10197-103E8	67.82	8.58	5.86	1.67	1.26	1.67	4.40	0.63	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	8.69	0.71	0.00	0.00	0.00	0.18	0.18	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.82	1.31	0.00	6.42	0.00	0.66	0.39	0.79	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	20.87	1.18	0.00	5.41	0.00	0.98	0.30	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.70	0.78	0.00	6.27	0.00	0.34	0.11	0.67	0.45
esophagus, adult, pool1	10015-101C6	75.70	12.10	1.06	0.42	0.53	1.91	1.06	1.59	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	103.44	12.15	0.00	0.13	0.00	1.50	0.63	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	166.61	19.32	2.41	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	63.13	6.31	0.00	0.00	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	132.45	7.44	0.00	1.49	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	107.77	10.32	2.29	1.15	4.59	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	68.50	13.12	8.74	2.91	2.91	1.46	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	70.68	25.17	2.03	1.02	4.32	2.54	0.51	0.76	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	32.31	1.28	0.00	0.13	0.00	2.82	0.77	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	42.26	1.90	0.00	0.00	0.00	2.14	0.71	1.42	0.00
frontal lobe, adult, pool1	10040-101F4	42.60	21.20	10.60	39.41	14.07	1.03	0.56	0.56	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	21.62	1.80	0.00	0.00	0.00	0.90	0.30	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	51.48	4.30	0.00	0.09	0.00	1.74	0.46	0.55	0.09
gall bladder, adult	10198-103E9	123.13	18.11	1.21	0.00	0.48	1.21	2.17	3.38	1.45
gamma delta positive T cells, donor1	11937-126A2	12.35	9.13	2.68	0.54	2.15	0.00	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	24.28	10.46	0.37	0.00	0.37	0.00	0.00	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	47.95	7.39	0.00	0.00	0.00	0.84	1.48	2.53	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.05	2.51	0.00	0.00	0.00	0.58	0.00	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	16.72	2.13	0.00	0.16	0.00	0.66	0.16	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	36.61	12.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	76.99	10.74	0.00	0.23	0.00	2.74	0.69	2.51	1.14
giant cell carcinoma cell line:LU65	10487-107B1	15.95	1.49	0.00	0.00	0.00	0.23	0.00	0.34	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	25.89	4.62	0.00	0.28	0.00	0.14	0.28	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	119.47	8.23	0.75	1.25	0.75	3.24	1.50	1.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.38	4.54	0.00	0.11	0.00	0.53	0.21	0.63	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.97	5.06	0.14	0.28	0.00	0.70	0.14	0.56	0.14
glioblastoma cell line:T98G	10485-107A8	52.65	6.40	0.00	0.22	0.00	0.44	0.66	0.22	0.22
glioma cell line:GI-1	10413-106B8	46.57	6.44	1.46	0.00	1.76	2.34	0.59	0.29	0.88
globus pallidus - adult, donor10196	10175-103C4	53.94	21.14	8.02	6.56	2.19	1.46	0.00	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	97.39	30.02	14.65	7.32	4.15	1.95	2.69	1.46	0.49
globus pallidus, adult, donor10258	10367-105F7	75.31	21.91	4.11	2.74	1.37	1.37	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	67.15	9.06	4.26	0.00	4.80	0.00	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	626.47	124.80	14.68	0.00	2.45	2.45	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	69.76	6.72	0.00	0.32	0.00	0.32	0.96	2.56	1.28
hIPS +CCl2, biol_rep1	14383-156B9	57.85	5.05	1.38	0.00	1.84	0.46	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	53.04	6.86	2.29	0.91	0.46	0.00	0.00	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	38.65	5.15	1.29	0.00	1.29	0.00	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	45.99	2.87	0.00	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	38.41	5.49	2.06	0.00	0.00	0.00	0.00	1.37	0.00
hIPS, biol_rep3	14382-156B8	51.86	17.66	6.62	2.21	1.10	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.53	3.45	3.16	1.44	15.23	0.00	2.01	0.86	0.57
heart - mitral valve, adult	10205-103F7	121.38	14.05	0.90	0.60	0.90	2.69	1.20	1.79	0.30
heart - pulmonic valve, adult	10206-103F8	121.59	13.86	0.52	0.52	1.57	1.05	0.00	0.52	1.31
heart - tricuspid valve, adult	10207-103F9	79.93	7.49	2.50	0.00	0.00	0.83	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	64.48	5.51	1.02	0.20	0.61	1.43	0.82	0.61	0.82
heart, adult, diseased, donor1	10051-101G6	120.94	8.94	1.70	0.85	0.85	2.55	1.70	4.26	2.55
heart, adult, pool1	10016-101C7	51.51	5.98	0.46	0.23	1.15	1.15	0.00	0.00	0.46
heart, fetal, pool1	10046-101G1	172.09	19.20	1.95	0.51	1.75	5.85	0.72	0.92	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	2.78	0.31	0.00	0.00	2.16	0.62	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	68.97	3.57	0.00	0.00	0.00	2.38	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	67.62	6.52	0.00	0.33	0.00	0.99	0.44	0.99	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	66.51	8.37	0.00	0.12	0.00	1.21	0.73	1.46	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	75.28	7.48	0.00	0.10	0.00	2.32	0.81	1.31	0.30
hepatoma cell line:Li-7	10484-107A7	54.27	5.89	0.00	0.44	0.00	0.89	0.67	1.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	21.11	3.82	5.13	0.50	8.64	0.60	0.30	0.30	0.20
hippocampus - adult, donor10196	10169-103B7	34.07	23.66	8.52	9.46	7.57	0.00	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	89.60	24.08	13.06	16.12	7.14	2.45	1.84	1.43	1.43
hippocampus, adult, donor10258	10374-105G5	45.81	19.42	2.99	23.40	17.93	0.50	0.50	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	32.78	10.57	7.75	0.70	17.98	0.35	2.11	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	31.74	4.27	1.83	0.61	0.00	0.61	1.83	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.40	3.34	0.39	0.00	0.00	0.20	0.59	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.98	5.59	0.51	0.25	0.51	0.76	0.25	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	46.24	9.59	2.82	0.56	0.56	2.82	2.82	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.60	7.75	2.58	0.52	1.29	1.03	5.16	2.07	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	55.80	7.21	2.28	0.00	1.14	0.38	3.04	1.14	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	96.34	11.97	3.21	0.29	2.34	1.17	4.67	2.34	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	74.75	15.08	3.88	0.86	1.51	2.15	4.95	1.51	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.00	13.35	3.75	0.00	2.09	0.83	2.09	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.88	3.79	2.60	0.47	4.26	0.24	1.66	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	60.43	7.07	4.66	1.29	3.54	1.13	4.02	1.77	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.78	5.39	6.06	0.00	1.35	2.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.22	2.82	0.16	0.00	0.16	0.31	0.16	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	18.18	5.90	0.49	0.49	0.00	0.00	1.47	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	3.49	0.87	0.00	0.00	0.00	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.23	10.50	2.67	0.00	1.53	2.29	3.05	1.53	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.00	7.41	3.49	0.44	1.31	1.31	3.05	1.31	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	60.97	8.50	1.50	0.50	0.00	0.50	2.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	103.62	22.23	1.70	0.57	1.70	1.51	2.83	0.94	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	90.94	26.37	2.27	0.00	1.36	0.45	2.27	2.73	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	88.65	21.93	3.76	0.31	1.88	1.88	1.57	1.57	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	42.13	7.19	2.45	0.33	1.63	0.82	1.96	1.14	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.13	6.10	1.74	0.00	2.90	1.74	2.03	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	57.69	14.05	2.69	0.30	0.90	0.30	1.79	1.49	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	28.64	3.69	0.92	0.18	0.18	0.37	1.11	0.92	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	24.53	2.57	1.43	0.00	0.57	1.14	0.86	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	33.48	4.08	1.22	0.41	0.00	0.41	1.63	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	44.01	5.99	1.76	0.00	1.41	0.35	1.76	3.17	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.08	4.12	2.22	0.00	0.63	0.63	2.53	1.27	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.97	4.54	2.72	0.91	1.82	0.30	1.82	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	10.86	4.14	0.00	4.14	0.52	2.59	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	51.80	9.96	3.32	0.00	3.32	1.33	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	56.18	7.44	2.57	0.00	2.31	0.51	0.51	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.11	5.62	4.86	0.26	2.05	1.02	0.77	1.53	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	47.71	9.09	6.06	0.00	2.27	0.76	0.76	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.22	4.03	4.03	0.00	1.34	0.00	2.02	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.50	4.35	0.72	0.00	0.24	0.97	0.72	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	29.41	4.90	0.89	0.89	0.45	0.00	0.89	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.10	3.41	0.49	0.49	0.00	0.00	1.46	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	54.40	5.81	4.58	0.31	0.31	0.92	2.44	1.22	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	61.81	6.51	3.25	0.00	0.00	3.25	6.51	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	69.17	9.60	3.64	0.66	0.66	0.33	2.98	1.65	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	76.07	10.40	6.02	0.55	2.19	2.19	3.83	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	82.15	16.28	6.15	0.00	2.17	1.09	2.53	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	83.99	12.81	2.49	0.00	1.78	0.36	3.20	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	59.67	2.39	2.39	0.00	2.39	0.00	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	77.19	9.75	4.33	0.68	2.84	2.30	2.98	0.81	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.64	4.31	2.16	0.27	1.89	0.00	0.54	0.00	0.27
immature langerhans cells, donor1	11904-125F5	24.21	4.60	7.99	9.93	45.28	0.97	4.36	0.00	3.15
immature langerhans cells, donor2	11905-125F6	42.78	6.34	3.96	2.38	24.56	0.00	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	54.51	23.66	16.18	42.49	22.33	1.42	0.66	0.66	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	25.36	8.78	0.00	0.33	0.00	1.95	0.33	0.98	0.33
kidney, adult, pool1	10017-101C8	65.28	6.71	0.80	0.20	0.60	1.00	0.40	0.50	0.90
kidney, fetal, pool1	10045-101F9	143.03	21.08	1.34	0.21	1.77	5.16	0.42	0.64	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.38	2.27	0.00	0.00	0.00	1.42	0.00	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.87	3.87	0.00	35.80	0.00	0.55	0.28	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.23	1.83	0.37	0.00	0.00	0.37	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	45.77	9.81	1.09	0.54	1.63	2.72	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	35.90	2.53	0.00	0.00	1.52	1.52	0.51	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	15.32	0.55	0.00	0.00	0.00	0.55	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	9.70	2.16	0.72	0.00	0.00	1.08	1.44	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	19.57	1.63	0.00	0.00	0.00	2.17	1.09	1.09	1.09
leiomyoma cell line:15425	10571-108B4	26.47	3.40	1.70	0.00	1.70	0.73	2.43	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	1.05	0.00	0.00	0.00	2.09	2.09	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	39.79	6.73	0.00	0.00	0.00	0.59	0.35	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	77.32	10.47	0.31	0.16	0.16	2.81	0.78	1.41	0.47
liposarcoma cell line:SW 872	10726-110A6	33.26	4.26	0.00	0.12	0.00	2.07	0.00	0.61	0.00
liver, adult, pool1	10018-101C9	39.71	4.70	0.00	0.00	0.16	0.49	1.46	0.49	0.16
liver, fetal, pool1	10086-102B5	21.64	7.53	0.94	0.00	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	75.54	20.56	18.67	8.02	3.06	1.90	1.90	1.02	1.02
locus coeruleus, adult, donor10252	10165-103B3	77.88	24.36	9.78	6.83	3.88	0.92	1.29	1.29	0.74
locus coeruleus, adult, donor10258	10375-105G6	47.68	16.08	5.36	9.59	1.97	0.56	1.97	3.10	1.69
locus coeruleus, newborn, donor10223	10362-105F2	89.17	20.61	6.73	3.79	1.26	0.42	4.21	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	18.27	1.38	0.00	0.00	0.00	0.42	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	2.07	0.00	0.00	0.00	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	6.59	0.26	0.00	0.00	0.00	0.26	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	69.70	17.25	0.71	0.24	0.47	1.89	1.42	0.24	1.06
lung, fetal, donor1	10068-101I5	162.40	29.40	1.14	0.29	2.28	0.86	0.86	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	90.27	22.45	1.37	0.00	0.46	2.29	2.29	2.29	0.46
lymph node, adult, donor1	10077-102A5	21.30	5.21	0.95	0.00	3.31	0.47	1.42	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	4.82	1.32	12.93	0.22	6.36	0.44	1.10	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.91	0.00	7.40	0.30	9.81	0.00	1.21	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	51.82	0.85	0.00	0.00	0.00	1.70	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	84.36	12.43	0.44	0.00	0.00	1.78	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	71.80	13.90	0.83	0.21	0.00	1.04	0.21	0.21	0.21
mature adipocyte, donor3	12233-129G1	63.06	10.19	0.47	0.00	0.00	1.42	0.24	0.24	0.24
mature adipocyte, donor4	12234-129G2	62.12	12.37	0.00	0.00	0.00	1.32	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.02	2.86	2.38	3.57	0.24	1.19	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	16.92	12.41	28.20	5.64	1.13	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	77.42	25.20	15.08	38.07	6.25	1.84	2.39	2.02	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	25.10	10.80	5.40	26.05	4.13	0.64	0.64	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	34.12	6.82	3.41	0.00	11.94	0.00	2.56	1.28	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	46.41	15.19	14.68	33.41	8.44	0.68	5.57	2.87	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	86.80	23.98	16.34	29.71	5.94	2.12	1.91	1.06	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	13.48	1.93	5.78	7.71	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.38	11.13	12.56	0.72	29.79	0.36	1.08	0.36	1.08
medulla oblongata - adult, donor10196	10174-103C3	70.09	20.77	7.14	4.54	3.24	0.00	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	97.99	27.09	8.20	3.41	3.72	1.55	1.39	2.01	1.24
medulla oblongata, adult, pool1	10038-101F2	99.26	33.39	13.63	4.65	3.84	1.80	0.49	0.73	0.49
medulla oblongata, newborn, donor10223	10361-105F1	102.77	20.14	8.33	0.35	3.47	1.39	3.12	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	54.25	9.30	2.66	0.44	4.21	0.66	1.11	1.11	0.89
medulloblastoma cell line:ONS-76	10759-110E3	26.17	1.22	0.00	0.12	0.00	1.35	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	31.19	7.19	0.00	0.14	0.00	0.43	0.57	0.29	0.14
melanoma cell line:G-361	10465-106H6	25.79	2.71	0.00	0.54	0.00	0.81	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	40.52	4.52	0.00	0.18	0.00	1.45	1.27	2.89	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	20.27	8.81	113.67	4.41	4.41	0.00	11.46	1.76	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	36.81	7.78	29.29	0.26	2.33	0.26	2.33	0.26	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	34.52	2.15	0.00	0.15	0.00	2.15	0.31	1.23	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	27.81	2.00	0.00	0.18	0.00	1.45	0.36	0.91	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.74	1.66	0.00	0.00	0.00	0.00	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.83	4.21	0.28	0.28	0.00	2.39	0.14	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.20	2.89	0.00	0.19	0.00	1.16	0.58	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	39.56	3.47	0.69	0.69	0.00	1.39	2.08	2.08	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.83	1.54	0.00	0.00	0.00	2.57	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.26	2.53	0.00	0.00	0.00	1.15	0.35	0.81	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.21	2.92	0.00	0.13	0.00	1.19	0.40	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.63	2.97	0.14	0.00	0.00	0.95	0.41	0.81	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.16	3.13	0.00	0.00	0.00	1.28	0.00	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	58.63	4.61	0.00	0.00	0.00	0.99	0.66	1.32	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.18	5.12	0.00	0.28	0.00	2.21	0.55	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.97	0.70	0.00	0.35	0.00	0.35	1.05	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.60	3.47	0.00	0.00	0.00	0.61	0.20	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.96	4.31	0.00	0.00	0.72	0.72	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	22.86	1.76	0.00	2.79	0.00	0.62	0.00	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.45	1.14	0.00	0.91	0.00	0.46	0.46	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	2.52	0.00	0.84	0.00	0.84	0.84	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.74	2.39	0.00	0.15	0.00	2.54	0.90	0.75	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.86	2.19	0.00	0.35	0.00	0.96	0.26	0.61	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	64.06	4.42	0.00	0.37	0.00	2.21	0.74	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	30.62	2.58	0.00	0.00	0.00	0.00	1.14	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	4.63	0.42	0.42	0.00	0.42	0.84	1.68	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.38	3.20	0.46	0.46	0.00	1.83	0.91	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	47.83	4.60	0.00	0.00	0.00	1.28	0.77	1.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	45.55	5.24	0.26	0.00	0.00	0.52	1.31	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	62.54	3.39	0.31	0.00	0.00	1.23	0.00	1.54	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.25	3.06	0.00	0.47	0.00	0.47	1.88	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	58.55	5.08	0.00	1.02	0.00	1.35	1.02	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	53.84	2.36	0.00	0.39	0.00	0.79	0.79	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	57.00	3.71	0.00	0.00	0.00	0.00	1.85	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	60.28	4.33	0.00	0.00	0.00	0.58	0.87	1.73	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	58.01	4.91	0.00	0.00	0.00	0.89	0.22	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	59.13	5.05	0.00	0.48	0.24	0.96	1.68	1.92	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	56.47	8.80	0.00	0.73	0.00	2.20	0.73	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.40	2.35	0.00	0.34	0.34	0.00	0.34	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	54.45	1.64	0.00	0.00	0.00	0.82	1.23	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	46.39	3.44	0.00	0.00	0.00	0.00	0.86	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	62.89	2.73	0.00	0.00	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	44.82	3.57	0.00	0.00	0.00	0.65	0.32	2.27	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	1.45	0.00	1.45	0.00	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	47.44	1.07	0.00	0.53	0.00	1.07	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	4.09	0.00	0.00	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	56.36	1.94	0.00	0.00	0.00	0.39	0.39	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	0.00	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	45.70	3.97	0.00	0.00	0.00	0.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	0.00	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.17	0.59	0.59	1.19	0.00	1.19	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	40.21	0.00	0.00	0.00	0.00	0.00	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	26.60	0.63	0.00	0.00	0.00	0.63	1.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.90	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.52	0.81	0.00	0.00	0.41	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.60	1.77	0.00	0.00	0.00	0.59	1.77	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.61	2.81	0.00	0.00	0.00	0.31	0.94	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	44.11	6.68	0.00	0.00	0.00	1.34	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	62.68	10.64	0.00	0.00	0.00	1.18	4.73	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	95.02	10.27	0.00	2.57	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	77.79	6.20	0.00	0.00	0.00	0.69	0.69	3.44	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	38.59	3.96	0.00	0.99	0.00	0.00	0.49	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	53.83	2.24	0.00	0.00	0.00	0.00	0.00	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	5.72	0.00	0.00	0.00	0.00	1.91	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.78	4.43	0.00	0.00	0.00	0.40	0.40	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	4.36	0.00	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	29.14	5.07	0.00	0.00	0.00	1.27	0.00	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.17	7.28	0.00	0.00	0.00	0.00	0.61	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	0.00	0.00	0.00	0.00	4.52	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	25.53	2.47	0.00	0.00	0.00	2.47	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	45.04	3.77	0.00	0.00	0.00	0.20	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.18	3.89	0.00	0.00	0.00	0.00	0.97	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	43.80	2.04	0.00	0.00	0.00	4.07	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.04	1.55	0.00	0.00	0.00	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.43	2.60	0.00	0.24	0.00	0.47	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	25.72	2.55	0.00	0.23	0.00	0.70	0.00	0.46	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	0.00	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.98	1.64	0.00	0.10	0.00	0.72	0.31	0.41	0.10
mesothelioma cell line:Mero-25	10850-111F4	17.48	4.31	0.00	0.00	0.00	0.00	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	34.23	2.44	0.00	0.24	0.00	0.98	0.73	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	44.95	3.76	0.00	0.00	0.00	0.00	0.66	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	28.65	1.05	0.00	0.00	0.00	0.53	0.26	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	37.79	1.87	0.00	0.17	0.00	1.19	0.17	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	43.22	2.78	0.00	7.84	0.00	0.76	0.76	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	43.48	2.28	0.00	0.21	0.00	0.21	1.04	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	16.07	1.49	0.00	0.00	0.00	0.17	0.33	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	22.44	2.17	0.00	0.54	0.00	0.18	0.54	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	27.16	3.59	0.00	19.30	0.00	0.68	0.17	1.20	0.34
mesothelioma cell line:NCI-H28	10845-111E8	94.15	10.18	0.00	38.42	0.00	1.53	2.04	1.53	0.51
mesothelioma cell line:No36	10857-111G2	20.55	2.94	0.00	11.42	0.00	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	38.75	2.44	0.00	0.54	0.00	0.54	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	26.87	14.39	0.38	15.35	2.30	0.00	0.77	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	12.82	5.01	2.20	32.24	3.18	0.24	0.73	0.37	0.61
migratory langerhans cells, donor3	11903-125F4	19.20	8.62	2.51	10.05	3.05	0.36	0.72	0.54	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.26	2.29	0.33	0.65	0.00	0.98	0.98	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.46	2.76	0.00	0.00	0.00	1.27	0.85	0.85	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.72	0.46	0.00	0.69	0.00	2.76	0.23	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.43	1.52	3.62	0.38	10.85	0.19	1.52	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.98	6.65	10.53	0.55	4.62	1.11	0.55	0.00	1.11
myeloma cell line:PCM6	10474-106I6	0.40	0.00	5.34	0.00	4.15	0.00	0.59	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.34	1.52	0.00	0.00	0.00	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	101.80	7.65	0.20	0.98	0.00	6.47	0.98	1.57	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.35	0.56	0.00	1.23	0.00	0.22	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.60	0.74	0.00	1.40	0.00	0.00	0.00	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	71.21	19.87	2.76	0.00	2.21	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	44.17	15.41	27.15	0.23	8.74	0.92	0.46	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	112.63	21.70	26.94	0.37	18.90	2.43	0.37	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	10.97	3.80	0.63	0.00	0.00	0.21	0.00	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	113.49	44.72	20.50	0.37	20.13	3.54	1.86	2.61	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.72	4.27	0.00	0.47	0.00	0.47	0.47	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	14.25	2.53	0.00	0.00	0.00	0.32	0.32	0.48	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	2.42	0.40	0.60	0.00	1.21	0.20	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	4.45	4.45	13.35	0.00	1.27	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	34.34	3.19	0.00	0.27	0.27	0.53	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	14.87	14.87	14.87	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	34.50	13.87	3.04	0.34	11.33	0.17	0.00	0.51	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.81	1.60	12.81	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.02	5.45	0.32	0.32	0.00	0.64	1.28	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	39.94	3.94	0.00	0.26	0.00	0.53	1.58	2.10	0.53
nucleus accumbens, adult, pool1	10037-101F1	45.93	19.40	11.53	21.19	11.53	1.12	0.37	0.37	0.37
occipital cortex - adult, donor10196	10172-103C1	55.63	6.18	28.85	18.54	16.48	0.00	0.00	0.00	6.18
occipital cortex, adult, donor10252	10163-103B1	95.81	22.81	26.84	22.81	4.56	1.88	2.95	1.61	1.88
occipital cortex, newborn, donor10223	10355-105E4	36.39	10.55	10.55	2.91	23.66	0.36	2.18	0.73	1.82
occipital lobe, adult, donor1	10076-102A4	48.28	11.55	8.13	23.09	9.71	1.84	3.15	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	87.97	50.63	63.51	1.72	54.92	1.29	12.01	0.43	1.72
occipital pole, adult, pool1	10036-101E9	42.57	19.08	19.63	18.84	9.86	0.79	0.55	0.08	0.32
olfactory region, adult	10195-103E6	44.52	21.78	7.83	30.76	7.26	0.76	2.87	0.96	2.29
optic nerve, donor1	10277-104E7	96.05	32.02	16.01	16.01	2.00	0.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	117.44	6.04	0.00	0.91	0.00	5.01	2.05	0.68	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	99.33	5.50	0.00	0.55	0.00	0.82	0.41	0.69	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.49	1.19	0.00	0.00	0.00	0.85	1.69	1.69	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.85	2.66	0.23	0.12	0.00	1.62	0.23	0.81	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	68.20	5.00	0.00	0.00	0.00	1.47	0.59	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	49.52	1.87	0.00	0.00	0.00	6.54	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	26.72	4.03	0.85	0.21	0.21	0.42	0.00	0.21	0.00
ovary, adult, pool1	10020-101D2	120.72	20.96	0.96	0.26	0.52	2.97	2.01	1.14	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.68	1.47	0.00	0.37	0.00	0.92	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	45.15	7.53	0.00	0.00	0.00	2.82	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	3.07	0.28	1.12	0.00	1.68	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.84	1.70	0.00	0.00	0.00	0.34	0.68	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	57.95	4.31	0.00	0.50	0.00	3.31	0.33	0.50	0.33
paracentral gyrus, adult, pool1	10035-101E8	41.37	19.95	12.45	24.89	10.34	1.01	0.55	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	88.08	36.70	2.94	9.54	4.40	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	38.56	12.23	16.93	20.69	6.58	0.00	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	75.53	21.38	16.25	32.21	5.99	0.86	2.00	2.28	2.00
parietal lobe, adult, pool1	10034-101E7	50.40	20.62	12.34	30.31	8.20	1.50	0.62	0.35	0.35
parietal lobe, fetal, donor1	10072-101I9	133.84	50.43	72.74	1.94	33.94	3.88	8.73	1.94	5.82
parietal lobe, newborn, donor10223	10356-105E5	41.12	12.34	10.47	0.00	29.53	0.37	1.50	0.37	1.87
parotid gland, adult	10199-103F1	49.33	8.02	0.62	0.00	0.62	0.62	0.62	0.62	0.00
penis, adult	10200-103F2	105.27	14.50	0.54	1.07	0.00	2.69	1.07	2.15	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.61	2.04	0.00	0.00	0.00	0.73	0.00	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	119.33	43.86	18.06	0.00	5.16	0.00	1.94	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	166.41	93.57	26.06	0.00	5.92	3.55	3.55	0.00	3.55
pineal gland, adult, donor10258	10377-105G8	134.82	45.78	11.91	1.25	1.88	0.00	1.88	1.25	3.76
pituitary gland - adult, donor10196	10180-103C9	31.37	17.20	11.13	0.00	2.02	0.00	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	68.80	24.50	18.76	0.00	0.52	0.00	0.52	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	48.52	19.58	7.66	0.85	0.85	1.70	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	25.26	4.19	2.37	0.97	1.94	0.65	0.75	0.32	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	2.12	0.79	3.18	0.40	8.74	0.00	1.32	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	74.86	10.58	0.00	0.31	0.00	1.56	0.47	1.09	0.93
pons, adult, pool1	10033-101E6	58.78	22.89	11.02	4.56	4.91	1.20	0.43	0.43	0.26
postcentral gyrus, adult, pool1	10032-101E5	49.25	21.01	17.35	22.67	9.24	1.31	0.44	0.52	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	121.30	23.01	2.09	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.04	2.04	0.00	0.00	0.00	0.58	0.29	0.44	0.00
prostate cancer cell line:PC-3	10439-106E7	91.30	6.72	0.00	0.54	0.00	3.09	0.91	2.00	0.18
prostate, adult, pool1	10022-101D4	77.09	11.61	1.27	0.18	1.18	2.81	1.09	1.00	0.63
putamen, adult, donor10196	10176-103C5	41.78	17.70	12.75	3.07	8.50	1.42	0.71	1.18	1.89
putamen, adult, donor10252	10152-102I8	37.25	7.84	5.88	3.92	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	9.84	1.09	1.09	1.09	1.09	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	30.44	11.11	4.59	1.21	4.83	0.97	0.24	1.21	0.97
putamen, newborn, donor10223	10365-105F5	86.21	18.74	3.00	0.00	3.75	0.75	3.75	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	21.24	2.04	0.00	0.29	0.00	0.58	0.00	0.00	0.58
rectum, fetal, donor1	10067-101I4	148.84	16.69	6.95	0.00	1.39	4.17	2.78	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.23	1.91	0.00	0.00	0.00	0.42	0.64	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.45	3.73	0.00	0.41	0.00	0.83	0.83	0.83	0.00
retina, adult, pool1	10030-101E3	134.49	33.40	2.29	1.09	1.49	3.68	0.89	1.39	0.80
retinoblastoma cell line:Y79	10475-106I7	19.23	9.09	7.27	0.52	2.60	0.00	0.26	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.37	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	69.18	9.28	0.00	0.00	0.00	0.56	1.12	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	59.11	2.27	0.00	0.00	0.00	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	36.58	2.59	0.00	0.16	0.00	0.97	0.32	0.32	0.00
salivary acinar cells, donor2	11772-123I8	45.16	4.96	0.00	0.00	0.14	1.51	1.51	1.10	0.41
salivary acinar cells, donor3	11773-123I9	54.29	5.96	0.00	0.66	0.00	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	78.93	15.44	0.57	0.00	0.00	0.57	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.09	2.02	0.34	0.25	0.00	0.51	0.17	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.21	1.88	0.35	0.24	0.12	1.18	0.35	0.35	0.12
seminal vesicle, adult	10201-103F3	84.12	10.58	21.69	1.59	1.59	1.06	7.94	1.06	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	1.46	0.49	22.59	0.00	0.97	0.00	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	1.01	0.00	0.00	0.00	0.00	0.75	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	33.12	1.00	0.00	0.00	0.00	0.00	0.00	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.18	2.15	0.13	0.13	0.00	0.54	0.13	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	16.03	2.21	0.00	0.44	0.00	0.22	0.00	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.87	1.81	0.00	0.52	0.00	0.65	0.26	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	131.94	14.19	0.00	1.42	0.00	2.84	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	48.57	6.60	0.36	0.12	0.60	1.44	0.84	0.36	0.36
skeletal muscle, fetal, donor1	10066-101I3	50.25	8.04	0.00	0.00	3.02	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	61.07	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	74.48	4.42	0.00	0.63	1.26	0.63	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	5.00	0.67	10.01	0.00	3.00	0.00	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	46.34	15.76	0.00	0.00	0.00	1.58	0.32	0.63	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.22	11.37	0.58	0.19	0.19	0.00	0.19	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	7.25	1.32	14.67	1.81	1.48	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	31.85	23.32	0.32	0.16	0.16	0.32	0.80	0.64	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.85	12.86	0.00	0.22	0.00	1.74	0.22	0.22	0.22
small intestine, adult, pool1	10024-101D6	92.21	14.69	1.91	1.67	0.48	1.31	1.19	0.60	0.72
small intestine, fetal, donor1	10064-101I1	47.17	12.53	1.23	0.25	1.72	0.98	0.98	1.72	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	42.06	9.23	0.00	0.00	0.00	1.03	0.00	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	77.54	10.86	0.26	0.00	0.00	1.29	1.29	2.07	0.26
somatostatinoma cell line:QGP-1	10781-110G7	10.99	2.68	0.00	0.00	0.00	1.88	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	73.18	21.33	13.31	6.19	1.15	0.69	4.13	2.75	2.29
spinal cord, adult, donor10252	10159-103A6	76.49	16.17	10.25	5.91	3.55	3.15	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	83.71	11.76	2.77	2.77	0.69	0.00	0.69	3.46	1.38
spinal cord, fetal, donor1	10056-101H2	88.43	24.39	18.90	2.44	15.25	2.44	6.71	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	101.95	15.15	4.13	1.38	2.76	0.92	2.76	0.00	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.67	2.09	0.15	0.30	0.45	2.84	0.30	0.45	0.30
spleen, adult, pool1	10025-101D7	90.53	24.78	3.52	0.33	4.19	0.88	0.99	0.33	0.66
spleen, fetal, pool1	10044-101F8	158.12	45.29	1.99	0.08	4.93	3.34	0.56	0.79	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.83	1.24	4.35	0.00	4.45	0.00	0.41	0.10	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.56	2.09	0.00	0.00	0.00	2.47	0.38	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.09	2.80	1.05	0.00	0.70	0.35	1.40	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	11.73	1.17	0.00	0.00	0.00	0.39	0.78	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	34.11	2.36	0.00	0.23	0.00	0.56	0.00	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.86	1.69	0.42	62.69	0.42	0.42	0.00	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	64.08	4.27	2.14	1.07	1.07	3.20	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	71.21	15.38	0.57	0.00	0.57	1.71	1.14	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	84.54	26.59	7.27	4.98	1.45	2.08	1.87	2.28	1.66
substantia nigra, adult, donor10258	10371-105G2	61.55	24.83	5.69	2.07	2.59	0.00	1.03	2.07	1.03
substantia nigra, newborn, donor10223	10358-105E7	107.40	19.78	9.19	0.71	4.24	0.00	2.12	0.00	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	56.40	14.44	5.96	0.46	4.59	0.92	0.92	1.15	1.15
temporal lobe, adult, pool1	10031-101E4	45.27	20.68	15.34	30.77	15.51	0.42	0.68	0.59	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	84.76	43.45	72.65	0.71	66.95	1.42	7.83	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	110.76	52.74	49.23	0.44	47.91	0.88	7.47	0.88	3.08
tenocyte, donor1	11763-123H8	52.37	3.14	0.35	0.70	0.00	2.09	3.14	2.09	0.35
tenocyte, donor2	11765-123I1	52.65	1.53	0.38	0.00	0.00	1.53	1.53	2.29	0.38
tenocyte, donor3	11768-123I4	31.51	2.22	0.37	0.74	0.00	1.11	0.74	1.85	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	38.92	3.23	2.72	0.34	0.51	0.51	0.34	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	25.90	1.08	0.00	0.00	0.00	0.46	0.00	0.31	0.46
teratocarcinoma cell line:PA-1	10807-111A6	36.26	3.56	0.00	0.00	0.00	1.08	0.15	0.46	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.96	3.17	3.43	0.00	0.51	1.90	0.76	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	97.57	9.45	2.27	0.76	0.38	2.27	1.13	2.65	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	61.51	9.16	0.65	0.44	0.22	2.51	0.44	0.65	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	49.51	8.47	9.45	0.33	0.65	0.33	1.63	1.95	1.95
testis, adult, pool1	10026-101D8	50.36	8.16	1.40	24.37	0.54	0.54	2.58	0.54	0.32
testis, adult, pool2	10096-102C6	33.83	8.57	0.45	37.89	0.45	0.45	1.35	1.35	0.45
thalamus - adult, donor10196	10168-103B6	86.11	25.39	11.04	3.31	4.42	1.10	3.31	1.10	1.10
thalamus, adult, donor10252	10154-103A1	92.36	22.82	9.38	9.53	2.19	1.25	1.88	1.41	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	83.14	30.79	3.08	4.62	3.08	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	47.27	12.35	4.12	1.65	2.31	1.32	0.66	0.99	0.33
thalamus, newborn, donor10223	10366-105F6	35.67	4.60	2.30	0.00	2.88	0.00	2.30	1.15	0.00
throat, adult	10209-103G2	113.10	14.98	0.75	0.25	0.75	1.50	2.25	2.00	0.75
throat, fetal, donor1	10061-101H7	62.77	12.49	1.22	0.30	1.52	3.05	1.22	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	11.13	5.17	3.18	0.20	4.17	0.00	0.40	0.40	0.79
thymus, adult, pool1	10027-101D9	47.22	23.56	1.29	0.40	4.97	0.20	1.99	0.50	0.70
thymus, fetal, pool1	10043-101F7	69.72	39.90	0.73	0.31	3.32	0.42	0.83	0.62	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.97	0.93	0.00	0.13	0.00	0.40	0.40	0.80	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	20.81	1.26	0.00	0.00	0.00	1.82	0.14	0.42	0.00
thyroid, adult, pool1	10028-101E1	128.40	19.78	0.37	0.00	0.00	4.29	1.40	1.12	0.84
thyroid, fetal, donor1	10060-101H6	107.57	15.03	1.05	0.53	1.58	3.95	0.53	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	138.58	18.48	3.08	3.08	0.00	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	66.98	12.56	0.93	0.70	0.70	0.70	3.26	1.40	1.16
tongue, fetal, donor1	10059-101H5	52.02	10.25	0.79	0.79	1.58	0.79	1.58	0.79	0.79
tonsil, adult, pool1	10047-101G2	68.22	13.22	4.91	0.40	7.11	1.70	0.50	0.00	0.20
trachea, adult, pool1	10029-101E2	49.65	6.30	0.82	1.47	0.74	1.39	0.33	0.16	0.33
trachea, fetal, donor1	10058-101H4	66.55	12.31	1.15	0.77	1.15	1.54	1.92	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.76	4.25	0.00	0.00	0.00	3.19	0.71	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	38.20	2.33	0.00	0.00	0.00	1.22	0.00	0.41	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	44.66	2.82	0.00	0.16	0.16	0.78	0.78	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	85.61	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.40	1.52	0.00	0.08	0.00	0.59	0.51	0.59	0.17
umbilical cord, fetal, donor1	10057-101H3	47.99	8.35	2.09	2.09	0.00	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	155.78	23.55	1.37	0.00	1.71	3.24	0.68	1.19	0.85
uterus, fetal, donor1	10055-101H1	94.71	11.77	3.07	1.54	3.58	4.10	0.51	1.54	1.54
vagina, adult	10204-103F6	89.18	15.51	0.65	0.00	0.00	1.94	1.94	0.65	0.00
vein, adult	10191-103E2	48.22	12.93	2.19	0.00	3.51	0.88	1.75	1.10	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	3.74	1.07	2.40	0.27	4.27	0.00	0.00	0.00	0.27